Download the whole Issue

EDITORIAL P.5

LEADING ARTICLE

Some strategic aspects of the Medical Unit of MIA in RT. M.V. Potapova P.6

HEALTH CARE ORGANIZATION

History and development perspectives of the Clinical hospital of the medical (unit) of ministry of internal affairs in the Republic of Tatarstan. F.I. Ishkineyev P.8

On the eve of the 70th anniversary of polyclinic of MU of MIA in RT. R.Sh. Khisamiyev, R.R.Shaimardanov P.10

ORIGINAL ARTICLES

Study of influence of метоprololi succinati on some parameters of chronic heart failure. N.B. Amirov, L.A. Galimzyanova, R.N. Amirova, E.B. Frolova P.15

Experience of ace-inhibitor hinapril application in arterial hypertension patients’ treatment. N.B. Amirov P.19

Study of efficiency eprosartan at the patients with various degrees of arterial hypertension. N.B. Amirov P.22

The efficiency of multifunctional massage bed «Nuga-Best NM 5000» appliance in complex treatment of patients with vertebragenous pathology. I.A.Bоurenina, D.R.Zakirova P.25

The efficiency of running magnetic field appliance in complex treatment of patients suffering from chronic prostatitis. I.A.Bоurenina, V.V.Khasanov P.27

The efficiency of kidney and ureter electrostimulation with sinusoidal modulated current in complex conservative treatment of urolithiasis. I.A.Bоurenina, V.V.Khasanov P.30

To a question of forecasting of cholelithiasis. N.V.Ekimova, V.B.Lifshits, A.V.Lomonosov, V.V.Arzhnikov, V.G.Soubbotina P.32

Systemic immunity parameters changes in bronchial asthma depending on the phase of the disease. G.L. Ignatova, I.A. Zakharova P.38

Atorvastatin efficiency in correction of dislipidemia. S.N. Orekhova, N.B. Amirov P.42

Factors forming the health of GIBDD staff. M.V.Potapova, O.R.Sokolova P.45

Acute and chronic pyelonephritis: status of problem and courses reduction of the morbidity. O.N.Sigitova, E.V.Arkhipov, R.M.Latypov P.48

Effects of physical rehabilitation in chernobyl atom electric station accident liquidators with chronic broncho-pulmonary pathology. S.Yu.Chikina, N.N.Mescherjakova, A.V.Chernjak, A.S.Belevski, A.G.Chouchalin P.53

Application of tiazide diuretic indapamide in treatment of patients with arterial hypertension. R.R.Jagfarova, N.B.Amirov P.60

Quality of life of patients with gallstone disease in early postoperative period after the laparoscopic cholecystectomy. M.F.Yaushev, A.V.Martynov P.64

REVIEWS

Outpatient treatment of transient ischemic attacuk. R.I.Saleyev, S.A.Souslov, R.Sh.Khisamiyev P.69

The heart rate variability. method and clinical application. E. V.Choukhnin, N.B.Amirov P.72

Clinical and functional characteristic of cardiorenal continuum. A.G.Shcherbakova, O.N.Sigitova, E.V.Arkhipov P.78

LECTURES

Chronic renal disease and chronic renal failure — current approaches to the terms, classification and diagnosis. O.N.Sigitova P.83

Methodological basis of contemporary rehabilitation (clinical lecture). I.A.Bourenina P.88

BRIEF ARTICLES

Occurrence and peculiarities of hypertensive syndrome and cardio-vascular diseases risk factors in employees of Ministry of Internal Affairs/ Ministry of extraordinary situations working in traffic inspectorate and anti-fire service. N.B.Amirov, A.A.Vizel, M.V.Potapova, F.I.Ishkineyev, E.B.Frolova, E.F.Merikova, V.V.Iskandarova, Ju.A.Afanasyeva, O.R.Sokolova, R.G.Khousnoutdinova P.93

Peculiarities of bronchoobstructive syndrome in employees of Ministry of Internal Affairs/Ministry of extraordinary situations working in traffic inspectorate and anti-fire service. A.A.Vizel, N.B.Amirov, M.V.Potapova, F.I.Ishkineyev, E.B.Frolova, E.F.Merikova, V.V.Iskandarova, Ju.A.Afanasyeva, O.R.Sokolova, R.G.Khousnoutdinova P.95

Ophthalmologist and venereologist joint work experience in the case of eyes Chlamydia infections. L.K.Bounakova, S.N.Kharitonova, E.V.Faizoullina P.98

Health level of internal affairs employees: perspectives of study. L.K.Bounakova, M.V.Potapova, E.V.Faizoullina P.100

Assessment of health resources in patients with psoriasis. L.K.Bounakova, E.V.Faizoullina, F.G.Sadykova P.101

Otomycosis in patients: system of diagnostics, treatment and rehabilitation. L.K.Bounakova, V.V.Egorova, E.V.Faizoullina P.102

Structural-functional changes in pancreas and its bloodstream in case of early experimental ischemia. R.K.Kadyrov P.103

DISCUSSIONS

Etiology, pathogenesis, principles of diagnostics and treatment of vascular insufficiency. B.M.Miroljubov P. 105

Prevention of venous thromboembolic complications in patients with long lasting immobilization of lower extremities. R.I.Saleyev, S.A.Souslov, M.V.Potapova P.112

TO GENERAL PRACTITIONER

Diagnostic and therapeutic tactics in patients with portal hypertension. A.U. Anisimov, A.F.Yakoupov, A.D.Junousova P.115

CLINICAL OBSERVATIONS

To differential diagnosis of portal hypertention. I.A.Gimaletdinova, S.R.Abdoulkhakov P.125

Goodpasture’s syndrom. L.Kh.Safargaleyeva P.128

Clinical case of atrial fibrillation and pulmonary embolism. E.B.Frolova, G.M.Kamalov, L.F.Mingazoutdinova, O.Ju.Mikhoparova P.130

NEW TECHNOLOGIES AND TOOLS

The rehabilitation antistress program for internal affairs officers fulfilling mission in North Caucasian region. I.A.Bourenina, F.I.Ishkineyev, E.B.Frolova P.133

EXPERIENCE EXCHANGE, INNOVATIONS

Medical aid quality expertise department of the Medical Sanitary Department of the Ministry of Internal Affairs on RT and its activity in 2007— 2008. A.D.Galioullin, M.V.Potapova, L.G.Gazimova P.136

Family doctor activity at the Russian enterprise in the Republic of Guinea. V.S.Morokov P.138

MEDICINE HISTORY

Historical aspects of development of studies on skin diseases. L.K.Bounakova, E.V.Faizoullina P.140

___

EDITORIAL

LEADING ARTICLE

Some strategic aspects of the Medical Unit of MIA in RT

M.V. Potapova, Medical Unit of MIA in RT, Kazan, Russia

HEALTH CARE ORGANIZATION

History and development perspectives of the Clinical hospital of the medical (unit) of ministry of internal affairs in the Republic of Tatarstan

F.I. Ishkineyev, Clinical hospital of MU of MIA in RT, Kazan, Russia

On the eve of the 70th anniversary of polyclinic of MU of MIA in RT

R.Sh. Khisamiyev, R.R.Shaimardanov, Medical Unit of Ministry of Internal Affairs in Republic of Tatarstan, Kazan, Russia

 

ORIGINAL ARTICLES

Study of influence of метоprololi succinati on some parameters of chronic heart failure.

N.B.Amirov, L.A.Galimzyanova, R.N.Amirova, E.B.Frolova

Department of General Practice of Kazan State Medical University, Kazan, Russia

Clinical Hospital of Medico-Sanitary Department of Ministry of Internal Affairs of Republic of Tatarstan, Kazan, Russia

Abstract. The purpose of research. Studying of clinic-instrumental parameters dynamics at patients with chronic
cardiac failure (CCF) on a preparation metoprolol treatment background. Material and methods. Research was carried out in 2 stages. On a Ist stage 47 patients were treated. The objective patients status estimation on a clinical condition estimation at CCF scale (CCES), bearableness of therapy, necessity and opportunity of a preparation doze increase were studied initially and in 2 weeks after the beginning of therapy. At II nd investigation phase proceeded supervision over patients, which on a Ist treatment stage have achieved the maximum tolerable or target metoprolol doze — 100 mg per day. Patients, who accepted metoprolol irrespective of our research
and have achieved preparation target doze too, were also included in research under the program of II stage. Under this program to the patients, accepting a preparation within 6 weeks as a minimum, clinic-instrumental research with an objective status estimation with definition of a clinical condition in points was carried out initially and in 1 month of target metoprolol dozes therapy. From instrumental researches were carried out ECG, ECHO, 6 minutes walking test for an estimation of changes in dynamics. Results. Health state improvement was subjectively marked by all patients. Objectively decrease of points on ШОКС from 4 down to 2,8 on a treatment background was marked. The reduction of heart rate from (79,7±9,1) to (71,6±7,9) also was marked. The average systolic blood pressure level (ASBP) in 2 weeks of treatment has decreased on 18 mm/Hg, and average diastolic blood pressure level (ADBP) — on 7,7 mm/Hg an item. The results of II investigation phase allow to draw a conclusion on subjective and objective CCF patients condition improvement on a background of metoprolol treatment in maximum transferable dozes within 1 month, that proves to be true by increase of walkings quantity at 6 minute walking test realization from (341,0±50,8) up to (371,0±57,2) m and by the tendency to improvement of myocardium functional abilities parameters on ECHO data. The increase of emission value fraction (EVF) from (55,7±6,45) up to (57,0±5,9)% was marked. Conclusions. The preparation does not render adverse action on chronic heart failure current in the first 2 weeks of therapy under a condition of cautious titration doze and condition indemnification background application. In a 1 month supervision on a preparation target dozes therapy background the patients condition improvement of marks, that proves to be true by physical tolerance increase and myocardium functional abilities improvement.

Key words: chronic heart failure, b-adrenoblockers, metoprolol.

 

References

1. Ol'binskaja, L.I. Rol' fundamental'nyh issledovanij v optimizacii farmakoterapii hronicheskoj serdechnoj nedostatochnosti / L.I.Ol'binskaja, Zh.M.Sizova // Praktikujushhij vrach.—№ 4.—2002.—S. 2—3.
2. Lopatin, Ju.M. Simpato-adrenalovaja sistema pri serdechnoj nedostatochnosti: rol' v patogeneze i vozmozh­nosti korrekcii / Ju.M.Lopatin // Serdechnaja nedostatochnost'.— 2003.—T. 4, № 2.—S.105.
3. Mareev, V.Ju. Rezul'taty naibolee interesnyh issle­dovanij Consilium medicum po probleme serdechnoj nedostatochnosti v 1999 godu / V.Ju.Mareev // Consilium medicum.—2001.—Jekstr. vypusk.
4. Okorokov, A.N. Lechenie boleznej vnutrennih organov / A.N.Okorokov // Minsk: Vyshejnaja shkola.—T. 3, kn.1.— S. 360.
5. Kobalava, Zh.D. Metoprolol SR/XL: usovershenstvovan­naja forma jetalonnogo b-blokatora / Zh.D.Kobalava, K.M.Gudkov // Kardiologija.—2003.—T. 43, № 9.—S.95— 97.
6. Preobrazhenskij, D.V. Sovremennye podhody k lecheniju hronicheskoj serdechnoj nedostatochnosti (po materia­lam Amerikanskoj kollegii kardiologov i Amerikanskoj associacii kardiologov 2001 g.) / D.V. Preobrazhen­skij, B.A. Sidorenko, T.A. Batyrliev [i dr.] // Consilium medicum.—2002.—T. 4, № 3.—S.159.

 

Experience of ace-inhibitor hinapril application in arterial hypertension patients’ treatment.

N.B.Amirov

Department of General Practice of Kazan State Medical University, Kazan, Russia

Clinical Hospital of Medico-Sanitary Department of Ministry of Internal Affairs of Republic of Tatarstan, Kazan, Russia

Abstract. The purpose of research. To study xinapril preparation hypotensive efficiency at patients with arterial hypertension I—II stage.
Methods of research. In research it is included 34 patients [among them 18 women and 16 men in the age of (32±67) years, middle age (50,7±9,2) years] with essential arterial hypertension (АH) I—II stage. The initial average systolic blood pressure level (SBP) has made (162,6±12,2) mm Hg, diastolic BP level (DBP) — (93,7±10,4) mm Hg an item. Duration of disease has made (7,4±4,2) year on the average. All patients were complexly surveyed before and after treatment. To all patients with the hypotensive purpose was appointed inhibitor angiotensin-converting enzyme — xinapril (akkupro) in an initial dose 10 mg once a day. Patients were observed within 30 days. The estimation of efficiency and titration of a preparation dose carried out each 10 days. Results: the hypotensive therapy which has been carried out within 30 days has allowed to lower systolic BP level (SBP) on 28,0 mm Hg (16,81%), and diastolic (DBP) on 9,1 mm Hg (9,7%) on the average. It was possible to achieve BP target level at 88,1% of patients. Selection of therapy was spent in 3 stages. On a Ist stage xinapril was appointed in an initial dose 10 mg once a day. Monotherapy on this dose was effective at 8 patients that has made 23,5% from total number of patients. The patients who have achieved BP target digits, continued treatment on this dose, and the rest selection of therapy with transition to II stage proceeded. At II stage, to the staying 26 patients who have not achieved BP target digits at the initial stage, the xinapril dose enlarged up to 20 mg once a day. At 14 from them, that has made 41,1% from all patients taken under the control, BP downstroke up to target values was achieved. At III stage of therapy selection, 12 patients at whom xinapril monotherapy in a dose 20 mg once a day appeared insufficiently effective, received in indapamide addition (arifon retard) in a dose 1,5 mg once a day. The combination appeared effective at 8 patients that has made 23,5% from total of patients. At them it was possible to reach BP target digits. At 2 patients receiving combined treatment hypotensive effect was good with downstroke of DBP level on 10 mm Hg an item. And to 2 patients with unsatisfactory BP downstroke was continued selection of therapy with assignment of prolonged calcium antagonists group preparation (amlodipine). The acceptability of preparations was good. Preparations cancellation cases because of by-effects development was not marked. The conclusion. Results of clinical observation allow to draw a conclusion on high hypotensive activity and a good acceptability of xinapril preparation in monotherapy at patients with a soft both moderate hypertonia and expediency of its combination with indapamide at patients with a high degree of an arterial hypertension.

Key words: arterial hypertension, xinapril monotherapy.

 

References

1.  Oganov, R.G. Profilakticheskaja kardiologija: ot gipotez k praktike / R.G.Oganov // Kardiologija.—1999.—№ 2.— S.4—9.
2. Zhdanova, O.N. Izolirovannaja sistolicheskaja arteri­al'naja gipertenzija u pozhilyh ljudej / O.N.Zhdanova // Arterial'naja gipertenzija.—2002.—T. 8, № 5.—S.181.
3. Karpov, Ju.A. Ingibitory angiotenzinprevrashhajushhego fermenta i lechenie arterial'noj gipertonii / Ju.A.Karpov // Praktikujushhij vrach.—2002.—№ 4.—S.23.
4. Ostroumova, O.D. Vozmozhnosti primenenija ingibitora angiotenzinprevrashhajushhego fermenta kvinaprila dlja le­chenija arterial'noj gipertenzii / O.D.Ostroumova, A.A.Zy­kova, M.V.Smirnov // Kardiologija.—2001.—№ 9.—S.87.

 

Study of efficiency eprosartan at the patients with various degrees of arterial hypertension.

N.B.Amirov

Department of General Practice of Kazan State Medical University, Kazan, Russia

Clinical Hospital of Medico-Sanitary Department of Ministry of Internal Affairs of Republic of Tatarstan, Kazan, Russia

Аstract. The purpose of research. To estimate eprosartan hypotensive activity in a doze 600 mg per day at the initial stage of therapy selection by the patient with various degrees of arterial hypertension. Methods of research. In research it is included 33 patients with essential arterial hypertension (АH). Middle age of patients (48,9+10,3) years. Among them 12 women which middle age has made (47,6+6,5) years and 21 man with middle age (49,2+10,8 )years. Average duration of disease has made (7,4+6,4) year. All patients were complexly surveyed before and after treatment. The estimation of patients life quality was carried out with the use of the standardized questionnaire created on basis of the Goeteborg Quality of Life Instrument (GQI). Duration of supervision has made 2 weeks. Results. Hypotensive therapy which has been carried out within 14 days has allowed to lower a level the SBP from (157,6+14,1) mm Hg down to (135,6+10,4) mm Hg (p<0,001), and a diastolic BP level (DBP) from (94,1+16,6) mm Hg down to (86,1+6,7) mm Hg (p<0,05). It was possible to achieve a target BP level at 24 patients (72,7%), and at 8 (24,2%) was received good hypotensive effect with reduction of DBP level on 10 mm Hg and more. At 1 patient (3%) hypotensive effect of a preparation was unsatisfactory, so that for him the further selection of therapy was continued. Bearableness of a preparation was good. On a therapy background parameters of life quality grew up, to what testifies the reduction of the score, typed at questionnaire from 22,1+6,2 down to 17,7+5,82. The conclusion. Results of clinical supervision allow to draw a conclusion on good bearableness and high hypotensive activity of a preparation eprosartan in monotherapy at patients with a soft and moderate hypertension already at the initial stage of hypotensive therapies selection, and about positive influence of effective BP reduction on life quality parameters.

Key words: arterial hypertension, eprosartan, quality of life.

 

References

1. Novyj preparat farmacevticheskoj kompanii «Solvej Farma»: [Jelektronnyj resurs].—htpp://www.solvay
2. Karpov, Ju.A. Ingibitory angiotenzinprevrashhajushhego fermenta i lechenie arterial'noj gipertonii / Ju.A.Karpov // Praktikujushhij vrach.—2002.—№ 4.—S.23.
3. Kabalava, Zh.D. Jeprosartan mezilat — novyj blokator receptorov AT II. Klinicheskie dostizhenija i perspekti­vy / Zh.D.Kabalava: [Jelektronnyj resurs].—htpp: // www.solvay

 

The efficiency of multifunctional massage bed «Nuga-Best NM 5000» appliance in complex treatment of patients with vertebragenous pathology.

I.A.Bоurenina, D.R.Zakirova

Department of Rehabilitology and Sports Medicine of Kazan State Medical Academy, Kazan, Russia Clinical Hospital of Medico-Sanitary Department of Ministry of Internal Affairs of Republic of Tatarstan, Kazan, Russia

Abstract. Efficiency of infrared massage stimulation appliance («Nuga-Best NM 5000» apparatus) in complex treatment of patients with low back pain conditioned by vertebragenous pathology has been examined. Received positive results indicate the advisability of including the described method (subject to absence of contraindications) into complex therapy of patients suffering from low back pain.

Key words: low back pain, lumbago, infrared massage stimulation.

 

References

1. Bogoljubov, V.M. Medicinskaja reabilitacija: rukovod­stvo: v 3 t. / V.M.Bogoljubov; pod red. V.M.Bogoljubova.— M., 2007.
2. Bodrova, R.A. Jeffektivnost' kombinirovannogo fi­zioterapevticheskogo vozdejstvija pri boljah v spine / R.A.Bodrova, A.A.Ismagilova // Nelekarstvennaja medi-cina.—2007.—№ 3.—S.42—45.
3. Vejn, A.M. Bolevye sindromy v nevrologicheskoj prak­tike / A.M.Vejn.—M.: MEDpress-inform, 2001.—368 s.
4. Gol'dblat, Ju.V. Nemedikamentoznye metody lechenija bolevyh sindromov / Ju.V.Gol'dblat // Nelekarstvennaja medicina.—2007.—№ 3.—S.20—25.
5. Gurlenja, A.M. Fizioterapija i kurortologija nervnyh bo­leznej / A.M.Gurlenja, G.E.Bagel'.—Minsk, 1989.—397 s.
6. Podchufarova, E.V. Bol' v pojasnichno-krestcovoj obla­sti: diagnostika i lechenie / E.V.Podchufarova // Russkij medicinskij zhurnal.—2004.—№ 10.—S.581—584.
7. Ponomarenko, G.N. Chastnaja fizioterapija: ucheb. poso­bie / G.N.Ponomarenko; pod. red. G.N.Ponomarenko.—M.: OAO «Izd-vo Medicina», 2005.—744 s.
8. Popov, P.S. Spravochnik po kurortologii i fiziotera­pii zabolevanij nervnoj sistemy / P.S.Popov.—Kishi-nev, 1989.—278 s.
9. Strelkova, N.I. Fizicheskie metody lechenija v nevrologii: metod. rekomendacii / N.I.Strelkova.—M., 1991.—315 s.
10. Ushakov, A.A. Sovremennaja fizioterapija v klinicheskoj praktike / A.A.Ushakov.—M.: ANMI, 2002.—364 s.
11. Habirov, F.A. Lechebno-reabilitacionnye meroprijatija pri vertebrogennyh boljah / F.A.Habirov, F.I.Devlika-mova, A.G.Nugajbekov // Vertebronevrologija.—2002.— № 1—2.—S.42—50.
12. Habirov, F.A. Rukovodstvo po klinicheskoj nevrologii pozvonochnika / F.A.Habirov.—Kazan': Medicina, 2006.—520 s.
13. Birklein, F. Mechanism-based treatment principles of neuropathic pain / F.Birklein // Fortsch. Neurol. Psychiatr.— 2002.—№ 70 (2).—R.88—94.
14. Gatchel, R.J. Lower back pain: psychosocial issues. Their importance in predicting disability, response to treatment and search for compensation / R.J.Gatchel, M.A.Gardea // Neurologic clinics.—1999.—Vol.17.—P.149—166.

 

The efficiency of running magnetic field appliance in complex treatment of patients suffering from chronic prostatitis.

I.A.Bоurenina, V.V.Khasanov

Department of Rehabilitology and Sports Medicine of Kazan State Medical Academy, Kazan, Russia Clinical Hospital of Medico-Sanitary Department of Ministry of Internal Affairs of Republic of Tatarstan, Kazan, Russia

Abstract. Magnetic field clinical practice in complex treatment of 40 patients suffering from chronic prostatitis of mainly noninfectious origin has been described. Received results indicate much higher efficiency in treatment applying running magnetic field than standard conventional treatment of patients. The results show advisability of including this method into complex therapy of patients suffering from chronic prostatitis.

Key words: chronic prostatitis, prostatodynia, pelvic pain syndrome, low-frequency magnetotherapy.

 

References

1. Bogoljubov, V.M. Medicinskaja reabilitacija: rukovod­stvo: v 3 t. / V.M.Bogoljubov; pod red. V.M.Bogoljubova.— M., 2007.
2. Gus'kov, A.R. Nasha koncepcija hronicheskogo prostatita / A.R.Gus'kov // Vrachebnoe soslovie.—2004.—№ 5—6.— S.46—50.
3. Esilevskij, Ju.M. Novye podhody k diagnostike i leche­niju hronicheskih prostatopatij / Ju.M.Esilevskij // Biomedicinskaja radiojelektronika.—2001.—№ 5—6.— S.40—52.
4. Kaprin, A.D. Hronicheskij abakterial'nyj prostatit / A.D.Kaprin, K.N.Milenin, K.V.Ivanenko // Materialy plenuma pravlenija Ros. obshhestva urologov, 8—10 ijunja 2004 g.—Saratov; M., 2004.—S.236—237.
5. Karpuhin, I.V. Fizioterapija v andrologii / I.V.Kar­puhin, A.A.Minenkov, A.A.Li.—M., 2000.—344 s.
6. Lopatkin, N.A. Rukovodstvo po urologii / N.A.Lopat-kin.—M.: Medicina, 1998.—T.1.—S.155.
7. Ponomarenko, G.N. Osnovy dokazatel'noj fizioterapii / G.N.Ponomarenko.—SPb.: VMedA, 2003.—224 s.
8. Ponomarenko, G.N. Chastnaja fizioterapija: ucheb. poso­bie / G.N.Ponomarenko; pod red. G.N.Ponomarenko.—M.: OAO «Izd-vo Medicina», 2005.—744 s.
9. Pushkar', D.Ju. Hronicheskij abakterial'nyj prosta­tit: sovremennoe ponimanie problemy / D.Ju.Pushkar', A.S.Segal // Vrachebnoe soslovie.—2004.—№ 5—6.— S.9—11.
10. Rukovodstvo po urologii: v 3 t. / pod red. N.A.Lopatki-na.—M., 1998.
11. Tkachuk, V.N. Sovremennye metody lechenija bol'nyh hro­nicheskim prostatitom: posobie dlja vrachej / V.N.Tkachuk // Kafedra urologii S.-Peterburgskogo gos. med. un-ta im. akad. I.P.Pavlova.
12. Ushakov, A.A. Sovremennaja fizioterapija v klinicheskoj praktike / A.A.Ushakov.—M.: ANMI, 2002.—364 s.
13. Jerektil'naja disfunkcija u bol'nyh hronicheskim pro­statitom / I.A.Abojan, S.V.Pavlov, S.V.Grachev [i dr.] // Materialy plenuma pravlenija Ros. obshhestva urologov, 8—10 ijunja 2004 g.—Saratov; M., 2004.—S.178.
14. Jakovlev, S.V. Infekcija mochevyvodjashhih putej: ucheb.-metod. posobie dlja vrachej / S.V.Jakovlev, I.I.Derevjan-ko.—M.: Media Medika, 2001.

 

The efficiency of kidney and ureter electrostimulation with sinusoidal modulated current in complex conservative treatment of urolithiasis.

I.A.Bоurenina, V.V.Khasanov

Department of Rehabilitology and Sports Medicine of Kazan State Medical Academy, Kazan, Russia Clinical Hospital of Medico-Sanitary Department of Ministry of Internal Affairs of Republic of Tatarstan, Kazan, Russia

Abstract. Efficiency of sinusoidal modulated current usage in complex conservative patient treatment has been examined. The received results indicate that complex medication and physical therapy allow to reserve pain syndrome of patients suffering from urolithiasis much earlier, to reach spontaneous passage in short time and to reduce consequently the possibility in open treatment necessity.

Key words: urolithiasis, nephrolithiasis, renal colic, electrostumulation.

 

References

1. Bogoljubov, V.M. Medicinskaja reabilitacija: rukovod­stvo: v 3 t. / V.M.Bogoljubov; pod red. V.M.Bogoljubova.— M., 2007.
2. Borisov, V.V. Prolit v lechenii i profilaktike nefro-litiaza / V.V.Borisov, V.V.Koptev, S.K.Enaleeva, Ju.A.Demerza // Urologija.— 2004.—№ 2.—S.38—40.
3. Karpuhin, I.V. Fizioterapija v andrologii / I.V.Kar­puhin, A.A.Minenkov, A.A.Li.—M., 2000.—344 s.
4. Kir'janova, V.V. Rol' lokal'noj vibroterapii v leche­nii MKB / V.V.Kir'janova, N.S.Tagirov, A.N.Akimov // Sovremennye aspekty organizacii i okazanija medicin­skoj pomoshhi v uslovijah mnogoprofil'nogo staciona­ra: sb. nauch.-prakt. rabot Elizavetinskoj bol'nicy.— SPb., 2002.—S.142—144.
5. Kir'janova, V.V. Fizioterapija v kompleksnom lechenii i profilaktike recidivnogo kamneobrazovanija / V.V.Kir'janova, B.K.Komjakov, N.S.Tagirov [i dr.] // Ak­tual'nye voprosy fizioterapii, kurortologii i vos­stanovitel'noj mediciny: sb. nauch.-prakt. tr.—SPb., 2004.—S.75—76.
6. Komjakov, B.K. Jendoskopicheskoe lechenie kamnej moche­tochnikov / B.K.Komjakov, B.G.Guliev, N.S.Tagirov [i dr.] // Sovremennye napravlenija v diagnostike, lechenii i profilaktike zabolevanij: sb. nauch.-prakt. rabot GMPB № 2 S.-Peterburg.—SPb., 2004.—Vyp. IV.— S.213—214.
7. Lechebnaja fizicheskaja kul'tura: spravochnik / pod red. V.A.Epifanova.—M.: Medicina, 2001.
8. Lopatkin, N.A. Rukovodstvo po urologii / N.A.Lopat-kin.—M.: Medicina, 1998.—T.1.— S.155.
9. Panin, A.G. Ul'trazvukovoe issledovanie v diagnostike MKB / A.G.Panin, A.N.Akimov, N.S.Tagirov [i dr.] // Vest­nik Sankt-Peterburgskoj gosudarstvennoj medicinskoj akademii im. I.I.Mechnikova.—2003.—№ 1.—S.147.
10. Ponomarenko, G.N. Osnovy dokazatel'noj fizioterapii / G.N.Ponomarenko.—SPb.: VMedA, 2003.—224 s.
11. Ponomarenko, G.N. Chastnaja fizioterapija: ucheb. poso­bie / G.N.Ponomarenko; pod red. G.N.Ponomarenko.—M.: OAO «Izd-vo Medicina», 2005.—744 s.
12. Sitdykov, Je.R. Jeffektivnost' pojasa «Fizomed» do i posle nefroureterolitotripsii / Je.R.Sitdykov // Vo­enno-medicinskij zhurnal.—2003.—№ 4.—S.51—52.
13. Tagirov, N.S. Primenenie lekarstvennogo jelektrofo­reza v kompleksnom lechenii u bol'nyh mochekamennoj bolezn'ju / N.S.Tagirov // Vestnik Sankt-Peterburgskoj gosudarstvennoj medicinskoj akademii im. I.I.Mech-nikova.—2006.—№ 2 (6).—S.159—161.
14. Ushakov, A.A. Sovremennaja fizioterapija v klinicheskoj praktike / A.A.Ushakov.—M.: ANMI, 2002.—364 s.

 

To a question of forecasting of cholelithiasis.

N.V.Ekimova, V.B.Lifshits, A.V.Lomonosov, V.V.Arzhnikov, V.G.Sоubbotina

Medico-saitary unit of department of internal affairs of Saratov’s region, Saratov, Russia

Abstract. Issues of cholelithiasis development at healthy people and at the patients, suffering by a chronic cholecystitis, are considered. Significant parameters are revealed. Discriminantal functions for the decision of problems of forecasting are calculated.

Key words: cholelithiasis, serum lipids, cholesterol, forecasting.

 

References

1. Bogdarin, Ju.A. Metabolizm lipidov pri holecisti­te / Ju.A.Bogdarin, E.V.Chernova // Jeksperimental'naja i klinicheskaja gastrojenterologija.—2003.—№ 5.— S.56—60.
2. Gor'kovskaja, I.A. Osobennosti zabolevanij zhelchevyvo-djashhih putej u razlichnyh jetnicheskih grupp mongoloidov v juzhnyh regionah Vostochnoj Sibiri / I.A.Gor'kovskaja, O.L.Garkun // Rossijskij gastrojenterologicheskij zhur-nal.—1999.—№ 4.—S.106.
3. Dadvani, S.A. Zhelchnokamennaja bolezn' / S.A.Dadvani, P.S.Vetshev, A.M.Shulutko, M.I.Prudkov.—M.: Izdat. dom «Vidar».—M., 2000.
4. Ivanchenkova, R.A. Lipoproteidy nizkoj plotnosti u bol'nyh zhelchnokamennoj bolezn'ju i holesterozom zhelch­nogo puzyrja / R.A.Ivanchenkova, N.V.Perova, N.D.Kislyj [i dr.] // Terapevticheskij arhiv.—2005.—№ 2.—S.10— 14.
5. Il'chenko, A.A. Sostojanie problemy zhelchnokamennoj bolezni v Moskve: rasprostranennost', diagnosti­ka, lechenie i profilaktika / A.A.Il'chenko // Tez. dokl. I Moskovskoj assamblei «Zdorov'e stolicy», 15—16 dek. 2002, Moskva.—M., 2002.—S.23—24.
6. Kulik, N.N. Ispol'zovanie fiziko-himicheskoj ocenki zhelchi v kachestve sovremennogo metoda diagnostiki i prognoza zabolevanij zhelchevyvodjashhih putej / N.N.Ku-lik, E.I.Shabunina, Ju.A.Bogdarin [i dr.] // Rossijskij gastrojenterologicheskij zhurnal.—2000.—№ 4.— S.127—128.
7. Labeznik, L.B. Zhelchnokamennaja bolezn'. Puti reshenija problemy / L.B.Labeznik, A.A.Il'chenko // Terapevtiches­kij arhiv.—2005.—№ 2.—S.5—10.
8. Loginov, A.S. Novoe v diagnostike i lechenii zhelchnoka­mennoj bolezni / A.S.Loginov // Terapevticheskij ar-hiv.—2001.—№ 2.—S.5—6.
9. Loginov, A.S. Vezikuljarnyj transport holesterina i formirovanie zhelchnyh kamnej / A.S.Loginov, Ju.H.Ma-rahovskij, S.M.Chebanov // Cirroz pecheni: (klinika, diagnostika, lechenie).—M.: CNIIG, 1990.—S.121— 122.
10. Polunina, T.E. Zhelchnokamennaja bolezn' / T.E.Polunina // Lechashhij vrach.—2005.—№ 2.—S.34—38.
11. Filimonov, M.I. Zhelchnokamennaja bolezn': algoritm diagnostiki i lechenija / M.I.Filimonov // Russkij me­dicinskij zhurnal.—2001.—T. 9, № 3—4.—S.8—16.
12. Cimmerman, Ja.S. Hronicheskij holecistit i ego klini­cheskie maski: diagnostika i differencial'naja dia­gnostika / Ja.S.Cimmerman // Klinicheskaja medicina.— 2006.—№ 5.—S.4—12.

 

Systemic immunity parameters changes in bronchial asthma depending on the phase of the disease.

G.L.Ignatova1, I.A.Zakharova2

1 Department of Therapy, Pulmonology and Professional Pathology of Ural State Medical Academy of Additional Education, Ekaterinburg, Russia

2 City Clinical-Diagnostic Department for Pulmonary Patients, Chelyabinsk, Russia

Abstract. Most frequents reasons leading to bronchial asthma exacerbations are analsed. It’s found out that during remission in case of severe asthma bronchial obstruction and bronchial hyperreactivity are still present. Immunogram parameters both in exacerbation and in remissioln are diverse and don’t have any tendencies. The latter can be due to the different reasons of exacerbations as well as different severity of the disease, age and sex of the patients, etc.

Key words: bronchial asthma, cause of the disease, immunity changes.

 

References

1. Rukovodstvo po diagnostike, lecheniju i profilaktike bronhial'noj astmy / pod red. A.G.Chuchalina.— M., 2005.—S.7—14.
2. Global initiative for asthma, 2006. Global burden of asthma: A summary GINA.
3. Knjazheskaja, N.P. Legkaja persistirujushhaja bronhial'naja astma. Voprosy diagnostiki, lechenija i kontrolja / N.P.Knjazheskaja // Atmosfera. Pul'monologija i aller-gologija.—2006.—№ 4.—S.26—30.
4. Rabe, K.F. Clinical management of asthma in 1999: the Asthma Insights and Reality in Europe (AIRE) study / K.F.Rabe, P.A.Vermeire, J.B.Soriano [et al.] // Eur. Respir. J.—2000.—№ 16.—R.802—807.
5. Chuchalin, A.G. Tjazhelaja bronhial'naja astma / A.G.Chuchalin // Consilium medicum.—2000.—№ 10.—S.31—33.
6. Fassahov, R.S. Patogenez bronhial'noj astmy / R.S.Fas-sahov // Materialy 3-go Kongressa IUATLD Evropejsko­go regiona, 14-go Ros. nac. kongr. po boleznjam organov dyhanija.—M., 2005.
7. Hamitov, R.F. Antibakterial'naja terapija u bol'nyh bronhial'noj astmoj s bessimptomnoj infekciej Mycoplasma rneumonia / R.F.Hamitov, L.Ju.Pal'mova, V.G.Novozhenov // Pul'monologija.—2007.—№ 1.—S.64— 68.
8. Tan, W.C. Viruses in asthma exacerbations / W.C.Tan // Curr. Opin. Pulm. Med.—2005.—Vol.11, № 1.—R.21—26.
9. Nicholson, K.G. Respiratory viruses and exacerbation of asthma in adults / K.G.Nicholson, J.Kent, D.C.Ireland // Ibid.—1993.—Vol. 307.—P.982—986.
10. Joao Silva, M. Role of viruses and atypical bacteria in asthma exacerbations among children in Oporto (Portugal) / M.Joao Silva, C.Ferraz, S.Pissarra [et al.] // Allergol Immunopathol. (Madr).—2007.—Vol.35, № 1.—R.4—9.
11. Sereda, V.P. Analiz haraktera podderzhivajushhej tera­pii u bol'nyh, gospitalizirovannyh s obostreniem bronhial'noj astmy: dannye shestiletnego nabljudenija / V.P.Sereda // Atmosfera. Pul'monologija i allergo-logija.—2005.—№ 2.—S.43—45.
12. Avdeev, S.N. Bronhial'naja astma v tablicah i shemah / S.N.Avdeev.—M.: Atmosfera, 2005.—S.40—42.
13. Bronhial'naja astma u vzroslyh. Atopicheskij dermatit: klinich. rekomendacii / pod red. A.G.Chuchalina.—M.: At­mosfera, 2002.—S.189—191.
14. Sidorova, L.D. Bronhial'naja astma i gastrojezofage-al'naja refljuksnaja bolezn': klinich. perspektivy / L.D.Sidorova, L.M.Kudelja, I.Nepomnjashhih [i dr.] // Bo­lezni organov dyhanija.—2006.—№ 1.—S.50—55.
15. Lavrova, O.V. Osobennosti techenija i lechenija bronhi­al'noj astmy v period beremennosti / O.V.Lavrova // Rossijskij allergologicheskij zhurnal.—2007.—№ 6.— S.36—41.
16. Latysheva, T.V. Infekcionnye zabolevanija dyhatel'­nogo trakta u bol'nyh s bronhial'noj astmoj / T.V.La­tysheva, E.N.Medunicyna // Ros. med. zhurnal.—2007.— T. 15, № 7.—S.601—603.
17. Akopov, A.L. Gastrojezofageal'naja refljuksnaja bolezn' u pacientov s hronicheskimi zabolevanijami organov dy­hanija / A.L.Akopov, D.I.Filippov, I.A.Zarembo [i dr.] // Bolezni organov dyhanija.—2006.—№ 1.—S.12—16.
18. Harju, T.H. Pathogenic bacteria and viruses in indused sputum or pharyngeal secretions of adults with stable asthma / T.H.Harju, M.Leinonen, J.Nokso-Koivisto [et al.] // Thorax.—2006.—Vol. 61.—R.579—584.
19. Agafonova, I.O. Ocinka stanu immunnoi sistemi u hvorih na bronhial'nu astmu ta pidhodi do individualijeovannoi terapii / I.O.Agafonova // Med. perspektivi.—1998.—T.3, № 2.—S.49—52.
20. Fedoseev, G.B. Bronhial'naja astma / G.B.Fedoseev, V.I.Trofimov.—SPb.: Normedizdat, 2006.—S.22—23.

 

Atorvastatin efficiency in correction of dislipidemia.

S.N.Orekhova, N.B.Amirov

Department of General Practice of Kazan State Medical University, Kazan, Russia

Clinical Hospital of Medico-Sanitary Department of Ministry of Internal Affairs of Republic of Tatarstan, Kazan, Russia

Abstract. The purpose of the research. Тo estimate atorvastatin’s hypolipidemia effect on initial level lipid-decreasing therapy. Methods of the research. Тhe issue included 50 patients. Among them 18 women, middle age (60,2±7,2) years, and 32 men, middle age (54,4±6,4) years. All patients were complexly surveyed before and after treatment. The criterion for including in issue were: documented ischemic heart disease (stable angina, postinfarction cardiosclerosis), total cholesterol level (TC) more than 5,0 mmol/l, cholesterol low density lipoproteins more than 3,0 mmol/l, concentration of triglicerids (TG) in blood whey less than 3,5 mmol/l. Ischemic heart disease was  confirmed at 31 patients (62%), among them 17 people with documentary confirmed heart attack with different prescription. It was revealed 12 patients (24%) with different arrhythmias. 38 patients were with arterial hypertension (76%). Duration of the arterial hypertension was (10,4±7,6) years. Acute stroke was in anamnesis vitae of 3 patients (6%). The researches (as an ECHO, ultrasonic dopplerography of vessels) revealed: aorta sclerosis at 28 patients (56%), brachiocephalic arteries at 16 patients (32%), low extremity arteries at 2 patients (4%). 30 patients were with superfluous body weight (60%). To all patients atorvastatin in a doze 10 mg per day for hypolipidemia purpose was appointed. The patients were supervised during 1 month. It was made biochemical blood test, which included analysis of lipid spectrum and liver function test for estimation the therapy effect after 1 month. For excluding possible statin’s influence on liver function test we estimated dynamic of alanine aminotransferase and aspartat aminotransferase during the treatment. The analysis of functional liver probe was made before the treatment and after month-long atorvastatin therapy. Results. Hypolipidemia therapy during 30 days allowed to lower total cholesterol level from (6,30±0,91) to (4,84±0,71) mmol/l (23,7%), thus level low density lipoproteins reduced from (4,38±0,61) to (2,73±0,87) mmol/l (37,6%), and level hi density lipoproteins increased from (1,37±0,28) to (1,51±0,34) mmol/l (10,2%). The initial level of aspartat aminotransferase was 20,2±0,24, and after one month — (19,8±0,65) units/liter (normally: from 9,0 to 48 units/liter). Level of alanine aminotransferase also not changed significantly — from (20,3±0,34) to (21,4±0,23) units/liter (normally: from 5,0 to 49 units/liter). This helps us to make the conclusion that month-long atorvastatin therapy in a doze 10 mg per day not reflects significantly on liver function test. The conclusion. Atorvastatin’s hypolipidemia therapy reduced total cholesterol, cholesterol low density lipoproteins, triglycerids and raised cholesterol hi density lipoproteins authentically during first month of treatment. We revealed no influence on liver function test.

Key words: lipid-decreasing therapy, atorvastatin.

 

References

1. Aronov, D.M. Statiny snizhajut smertnost' i uluchshajut techenie ateroskleroticheskih zabolevanij / D.M.Aronov // Consilium Medicum.— 2001.—T.1, № 10.
2. Karpov, Ju.A. Faktory riska IBS: kogda i kak provodit' korrekciju? Povyshenie roli statinov / Ju.A.Karpov, E.V.Sorokin // Ros. med. zhurnal.— 2003.—T. 11, № 9.
3. Scandinavian Simvaststin Survival Study Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvaststin Survival Study (4S) // Lancet.—1994.—Vol.344.—R.1383—1389.
4. Sever, P.S. «Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower—than—average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial—Lipid Lowering Arm (ASCOT—LLA): a multicentre randomised controlled trial» / P.S.Sever, B.Dahlof, N.R.Poulter [et al.] // Lancet, 2003.

 

Factors forming the health of GIBDD staff.

M.V.Potapova, O.R.Sokolova

Medico-Sanitary Unit of Ministry of Internal Affairs of Republic of Tatarstan, Kazan, Russia

Abstract. Prominent in building and maintaining health is identifying risk factors and conditions conducive to their emergence. These factors include natural and social environment, lifestyle factors of people and individual characteristics of the organism. The nature and extent of the risk factors in the environment determine the severity of medical and environmental situation, which is the main and decisive part of sanitary-epidemiological wellfare of the population. Modern comparative risk analysis methodology provides a parallel review of health risks, environmental risks arising from breach of quality components of ecosystems and harmful effects on aquatic and terrestrial organisms (except Rights), the risks associated with quality, the living conditions, including the risk of uncomfortable conditions.

Key words: health, risk factors, environment, image, living conditions, ecosystem.

 

References

1. Амиров, Н.Х. Разработка системы генетического конт­роля факторов внешней среды / Н.Х.Амиров // Мутаге­ны и канцерогены окружающей среды. Проблемы анти-мутагенеза.—Казань, 2004.—С.3—4.
2. Зыятдинов, К.Ш. Социально-гигиенический мониторинг здоровья: автореф. ... канд. мед. наук / К.Ш.Зыятдинов.— Казань, 1996.—22 с.
3. Онищенко, Г.Г. Современные проблемы ведения и со­вершенствования социально-гигиенического монито­ринга / Г.Г.Онищенко // Материалы пленума научного совета по экологии человека и гигиене окружающей сре­ды РАМН и МЗ РФ.—М., 2003.—С.3—14.
4. Переведенцев, Ю.П. Динамика климата города Казани в современный период / Ю.П.Переведенцев // Совре­менная география и окружающая среда: тез. докл. Все-рос. науч. конф.—Казань, 1996.—С.28—31.
5. Переведенцев, Ю.П. Состояние воздушного бассейна и климатические условия рассеивания примесей на тер­ритории Татарстана / Ю.П.Переведенцев // Окружающая среда и здоровье: тез. докл. регион. науч. конф.—Казань, 1996.—С.91—92.
6. Рахманин, Ю.А. Научные проблемы совершенствования социально-гигиенического мониторинга / Ю.А.Рахманин // Материалы пленума научного совета по экологии че­ловека и гигиене окружающей среды РАМН и МЗ РФ.— М., 2003.—С.311—314.
7. Сидоренко, Г.И. Методология изучения состояния здо­ровья населения / Г.И.Сидоренко // Гигиена и санита-рия.—1998.—№ 4.—С.3—9.
8. Титова, А.А. Оценка воздействия неблагоприятных факторов окружающей среды на репродуктивную функцию: автореф. дис. ... канд. мед. наук / А.А.Титова.—Казань, 2001.—28 с.

 

Acute and chronic pyelonephritis: status of problem and courses reduction of the morbidity.

O.N.Sigitova, E.V.Arkhipov, R.M.Latypov

Department of General Practice of Kazan State Medical University, Kazan, Russia Clinical-Вiagnostical Сentre of Aviastroitelniy District, Kazan, Russia

Abstract. Morbidity of acute and chronic pyelonephritis in adult population was studied in the Republic of Tatarstan for the period of 2002—2007. Expertise of medical care to patents with urinary tract infection before instillation of clinical protocols for the period managing such kind of patents and after there adoption was performed. Clinical protocols were developed on principles and data of evidence-based medicine. Clinical protocols allow to improve the quality of medical care of patents, which without in reduction of incidence of chronic pathology formation.

Key words: pyelonephritis, epidemiology, chronic renal failure, clinical protocols managing of ills, evidence-based medicine.

 

References

1. Asplund, Shh. Ispol'zovanie principov nauchno-doka­zatel'noj mediciny v klinicheskoj praktike / Shh.Asplund // Rossijskij semejnyj vrach.—2000.—№ 3.— S.57—58.
2. Biskup, A.B. Rossijskij vzgljad na ocenku medicinskih tehnologij i nauchno-dokazatel'nuju medicinu / A.B.Bis-kup // Rossijskij semejnyj vrach.—2000.—№ 3.—S.67— 69.
3. Denisov, I.N. Obshhaja vrachebnaja praktika (semejnaja medicina): process stanovlenija i perspektivy razvi­tija / I.N.Denisov // Vestnik semejnoj mediciny.— 2004.—№ 1.—S.4—10.
4. Korovina, N.A. Protokol diagnostiki i lechenija pielo­nefrita u detej / N.A.Korovina, I.Ja.Zaharova, Zh.Mum-ladze, L.L.Gavrjushova.—M., 2003.—72 s.
5. Kulikov, O.A. Principy i opyt sozdanija standartov dejatel'nosti VOP: opredelenie optimal'nyh ob#emov medicinskoj pomoshhi VOP i obespechenie jeffektivno­go vzaimodejstvija s «uzkimi» specialistami / O.A.Ku­likov, E.V.Belorukov, I.V.Sokolova [i dr.] // Tez. II
6. Vse-ros. s#ezda vrachej obshhej (semejnoj) praktiki RF, 28— 30 sent. 2004 g. , Cheboksary.—Cheboksary, 2004.—S.51— 52.
7. Petrov, V.N. Infekcija mochevyh putej u vzroslyh / V.N.Petrov, A.G.Zaharchuk // Rossijskij semejnyj vrach.—2001.—T.5, № 4.—S.4—10.
8. Plavinskij, S.L. Pochemu my nachinaem govorit' o nauch­no-dokazatel'noj medicine? / S.L.Plavinskij // Ros­sijskij semejnyj vrach.—2000.—№ 3.—S.59—65.
9. Rafal'skij, V.V. Rezistentnost' vozbuditelej ambu­latornyh infekcij mochevyvodjashhih putej po dannym mnogocentrovyh mikrobiologicheskih issledovanij UTIAP-I, UTIAP-II / V.V.Rafal'skij, L.S.Strachunskij, O.I.Krechikova [i dr.] // Urologija.—2004.—№ 2.— S.1—5.
10. Renkvist, N. Skandinavskaja model' monitoringa i ocen­ki rezul'tatov i kachestva medicinskoj pomoshhi / N.Ren-kvist // Rossijskij semejnyj vrach.—2000.—№ 3.— S.70—71.
11. Safina, A.I. Differencirovannyj podhod k antibak­terial'noj terapii pielonefritov u detej g. Kazani s uchetom techenija zabolevanija i vozrasta / A.I.Safi-na // Nefrologija i dializ.—2004.—T.6, № 3.—S.253— 261.
12. Sigitova, O.N. Vnebol'nichnyj pielonefrit: vozmozhno­sti i puti optimizacii lechenija / O.N.Sigitova, E.V.Ar- hipov, O.A.Gur'janov [i dr.] // Kazanskij medicinskij zhurnal.—2007.—T.88, № 4 (pril.).—S.258—259.
13. Fedoseeva, L.S. Upravlenie kachestvom okazanija me­dicinskoj pomoshhi na ambulatornom jetape / L.S.Fe­doseeva, N.I.Kantemirova, V.N.Kozak, T.A.Larina // Tez. II Vseros. s#ezda vrachej obshhej (semejnoj) prak­tiki RF, 28—30 sent. 2004 g., Cheboksary.— Cheboksary, 2004.—S.88—89.
14. Shevelev, A.N. Sovremennye principy vedenija paci­entov s neoslozhnennymi infekcijami mochevyh putej / A.N.Shevelev, L.S.Strachunskij // Medicina.—2005.— № 2 (9).
15. Dolan, J. Can decision analysis adequately represent clinical problem? / J.Dolan // J. Clin. Epidemiol.—1990.—Vol. 43.— P.277—284.
16. Geerlings, S.E. Consequences of asymptomatic bacteriuria in women with diabetes mellitus / S.E.Geerlings, R.P.Stolk, M.J.Camps [et al.] // Arch. Intern. Med.—2001.—Vol.161.— R.1421—1427.
17. Guyatt, G. Users’ guide to the medical literature. XVI. How to use a treatment recommendation / G.Guyatt, J.Sinclair, D.Cook, P.Glaszion // JAMA.—1999.—Vol.281.—P.1836— 1843.
18. Sackett, D.L. Evidence-Based Medicine. How to practice and teach EBM / D.L.Sackett, S.S.Straus, W.S.Richardson [et al.]; 2nd ed.—Churchill Livingston, Edinburgh, 2000.— 261 p.
19. Talan, D.A. Comparison of ciprofloxacin (7 days) and trimethoprim-sulfamethoxazole (14 days) for acute uncomplicated pyelonephritis in women: a randomized trial / D.A.Talan, W.E.Stamm, T.M.Hooton [et al.] // JAMA.— 2000.—Vol.283.—R.1583—1590.
20. Thomton, J. Management for Doctors; Decision analysis for medical managers / J.Thomton, R.Lilford // BMJ.—1995.— Vol.310.—P.791—794.
21. Toporovski, J. Effectiveness of cefetamet pivoxil in the treatment of pyelonephritis in children / J.Toporovski, L.Steffens, M.Noack [et al.] // Journal of International Medical Research YR.—1992.—Vol.20, № 1.—P.87—93.
    Warren, J.W. Guidelines for antimicrobial treatment of uncomplicated acute bacterial cystitis and acute pyelonephritis in women. Infectious Diseases Society of America (IDSA) / J.W.Warren, E.Abrutyn, J.R.Hebel [et al.] // Clin. Infect. Dis.—1999.—Vol.29.—S.745—758.

 

Effects of physical rehabilitation in Chernobyl atom electric station accident liquidators with chronic broncho-pulmonary pathology.

S.Yu.Chikina, N.N.Mescherjakova, A.V.Chernjak, A.S.Belevski, A.G.Chоuchalin

Scientific-Research Institute of Pulmonology of Federal Medico-Biologic Agency, Moscow, Russia

Abstract. The influence of physical rehabilitation on the dynamics of functional state of Chernobyl atomic electric station accident liquidators. Physical reabilitation improves tolerance to physical execises, but does’t influence pulmonary function probably because of the fact that special exercises for respiratory muscle weren’t included intothe programm of rehabilitation.

Key words: physical rehabilitation, Chernobyl atomic electric station accident liquidators, tolerance to physical exercises, radionuclid-induced pneumopathy.

 

References

1. Kirjuhin, A.V. Otdalennye rezul'taty nabljudenija i le­chenija patologii organov dyhanija u uchastnikov likvida­cii posledstvij avarii na Chernobyl'skoj AJeS vo Vla­dimirskoj oblasti: dis. ... kand. med. nauk / A.V.Kirju-hin.—M., 1999.
2. Kopylev, I.D. Osobennosti zabolevanij organov dyha­nija u likvidatorov avarii na Chernobyl'skoj AJeS, pro­gramma ih lechenija i reabilitacii / I.D.Kopylev, S.P.Ammosova, A.V.Maracheva [i dr.]; pod red. A.G.Chucha-lina, A.L.Chernjaeva, K.Vuazena // Patologija organov dy­hanija u likvidatorov avarii na Chernobyl'skoj AJeS.— M.: Grant#, 1998.—S.165—176.
3. Svirina, V.I. Rasprostranennost' hronicheskih obstruk-tivnyh zabolevanij legkih u uchastnikov likvidacii po­sledstvij avarii na ChAJeS / V.I.Svirina, S.S.Jakushin, E.A.Smirnova, I.V.Reshetova // 7-j Nacional'nyj kong­ress po boleznjam organov dyhanija: sb. rezjume.—M., 1997.—№ 1210.
4. Standartizacija legochnyh funkcional'nyh testov // Pul'monologija.—1993.—Pril. 1.—S.165.
5. Chikina, S.Ju. Kliniko-morfologicheskaja i geneticheskaja harakteristika bronholegochnoj sistemy u likvidato­rov posledstvij avarii na Chernobyl'skoj AJeS v otda­lennye sroki: dis. ... kand. med. nauk / S.Ju.Chikina.—M., 2002.
6. Jakushin, S.S. Kliniko-morfologicheskie osobennosti patologii organov dyhanija u likvidatorov posledstvij avarii na Chernobyl'skoj AJeS / S.S.Jakushin, V.M.Zajchi-kov, G.K.Cinkina // 7-j Nacional'nyj kongress po bolez­njam organov dyhanija: sb. rezjume.—M., 1997.—№ 1217.
7. American Thoracic Society. Lung function testing: selection of reference values and interpretative strategies // Am. Rev. Respir. Dis.—1991.—№ 144.—R.659—692.
8. American Thoracic Society. European Respiratory Society statement on pulmonary rehabilitation // Am. J. Respir. Crit. Care Med.—2006.—№ 173.—R.1390—1413.
9. ATS statement: guidelines for the six-minute walk test // Am. J. Respir. Crit. Care Med.—2002.—№ 166.—R.111—117.
10. Beckerman, M. The effect of 1 year of specific inspiratory muscle training in patients with COPD / M.Beckerman, R.Magadle, P.Weiner // Chest.—2005.—№ 128.—R.3177— 3182.
11. Belman, M.J. Targeted resistive ventilatory muscle training in chronic obstructive pulmonary disease / M.J.Belman, R.Shadmehr // J. Appl. Physiol.—1988.—№ 65.—R.2726— 2735.
12. Black, L.F. Maximal inspiratory pressures: normal values and relationship to age and sex / L.F.Black, R.E.Hyatt // Am. Rev. Respir. Dis.—1959.—№ 99.—R.696—702.
13. Dyspnea. Mechanisms, assessment and management: a consensus statement // Am. Respir. J. Crit. Care Med.— 1999.—№ 159.—R.321—340.
14. Enright, P.L. Reference equations for the six-minute walk in healthy adults / P.L.Enright, D.L.Sherrill // Am. J. Respir. Crit. Care Med.—1998.—№ 158.—R.1384—1387.
15. MacNee, W. Pulmonary rehabilitation / W.MacNee // Clinical Management of Chronic Obstructive Pulmonary Disease / ed. W.MacNee, R.L.ZyWallack, J.Keenan.— USA: Professional Communications, Inc., Caddo, 2005.
16. Mador, M.J. Effect of respiratory muscle endurance training in patients with COPD undergoing pulmonary rehabilitation / M.J.Mador, Q.Deniz, A.Aggarwal [et al.] // Chest.—2005.— № 128.—R.1216—1224.
17. Palange, P. Ventilatory and metabolic adaptations to walking and cycling in patients with COPD / P.Palange, S.Forte, P.Onorati [et al.] // J. Appl. Physiol.—2000.—№ 88.— R.1715—1720.
18. Pelegrino, R. Interpretative strategies for lung function tests / R.Pelegrino, G.Viegi, V.Brusasco [et al.] // Eur. Respir. J.— 2005.—№ 26.—R.948—968.
19. Porszasz, J. Exercise training decreases ventilatory requirements and exercise-induced hyperinflation at submaximal intensities in patients with COPD / J.Porszasz, M.Emtner, S.Goto [et al.] // Chest.—2005.—№ 128.—R.2025—2034.
20. Pulmonary rehabilitation: joint ACCP/AACVPR evidence-based clinical practice guidelines // Chest.—2007.—№ 131.— S.4— 42.
    Sewell, L. How long should outpatient pulmonary rehabi­litation be? A randomised controlled trial of 4 weeks versus 7 week /
21. L.Sewell, S.J.Singh, J.E.A.Williams [et al.] // Thorax.—2006.—№ 61.—R.767—771.
22. Verrill, D. The effects of short-term and long-term pulmonary rehabilitation on functional capacity, perceived dyspnea, and quality of life / D.Verrill, C.Barton, W.Beasley, W.M.Lippard // Chest.—2005.—№ 128.—R.673 — 683.

 

Application of tiazide diuretic indapamide in treatment of patients with arterial hypertension.

R.R.Jagfarova, N.B.Amirov

Department of General Practice of Kazan State Medical University, Kazan, Russia

Clinical Hospital of Medico-Sanitary Department of Ministry of Internal Affairs of Republic of Tatarstan, Kazan, Russia

Abstract. The purpose of research: estimation of indapamide 2,5 mg per day antihypertensive activity at monotherapy and in a combination with inhibitor of angiotenzin converting enzyme enalaprili maleati. Methods of research: In research included 30 patients with essential arterial hypertension (АH). Among them 16 women, middle age (42,7±9,9) years, and 14 men, middle age (46,1±11,1) years. Average duration of disease has made (2,9±0,4) years. The initial systolic blood pressure (SBP) level has made (153,4±3,7) mm Hg, diastolic blood pressure (DBP) level — from (99,7±2,5) mm Hg on the average. The patients were complexly surveyed on the developed algorithm of inspection of the patients with arterial hypertention. To all patients tiazide diuretic indapamide in a doze 2,5 mg per day with hypotensive purpose was appointed. The therapy effect was estimated in 8 weeks. If sufficient effect was achieved — indapamide monotherapy proceeded. At absence of effect within 8 therapy weeks, the inhibitor of angiotenzin converting enzyme (iACE) enalapril-maleat — in an initial doze 10 mg once a day — was attached to treatment. Patients were observed within 14 weeks. For therapy efficiency after 14 therapy weeks estimation a whole day BP monitoring was carried out. Results: indapamide monotherapy, carried out during 8 weeks, was effective at 17 patients (58,0%). In this patients group authentic decrease of SBP level for whole day, day and night accordingly on 16,5; 16,0 and 12,5 mm Hg is marked. Daily average, day time and night DBP has decreased accordingly on 10,2; 8,8 and 11,4 mm Hg. The SBP variability index also decreased on 27,5%, DBP on 30,0%, that proves a reduction of hypertonic pressure on indapamide monotherapy background. At II stage, to the staying 13 patients, who have not achieved target BP figures at the initial stage, enalapril maleat in a doze 10 mg once a day was attached to treatment. At 10 of them, that has made 33,3% from all patients taken under the control, decrease of BP up to target values was achieved. To 3 patients, at whom indapamide therapy in a doze 2,5 mg per day and enalapril maleat in a doze 10 mg once a day appeared insufficiently effective, selection of therapy with connection of calcium antagonists was continued. Bearableness of preparations was good. Cancellation cases because of by-effects development was not marked. Conclusions. Results of clinical supervision allow to draw a conclusion on good bearableness and high hypotensive activity of indapamide preparation monotherapy at patients with a soft and moderate hypertension. The influences of indapamide preparation on metabolic processes was not revealed. Enalapril to indapamide addition allows to strengthen hypotensive preparation effect and to achieve target values of B P.

Key words: arterial hypertension, indapamide, ACE-inhibitor.

 

References

1. Oganov, R.G. Profilakticheskaja kardiologija: ot gipotez k praktike / R.G.Oganov // Kardiologija.—1999.—№ 2.— S.4—9.
2. Zhdanova, O.N. Izolirovannaja sistolicheskaja arteri­al'naja gipertenzija u pozhilyh ljudej / O.N.Zhdanova // Arterial'naja gipertenzija.—2002.—T. 8, № 5.—S.181.
3. Karpov, Ju.A. Ingibitory angiotenzinprevrashhajushhego fermenta i lechenie arterial'noj gipertonii / Ju.A.Karpov // Praktikujushhij vrach.—2002.—№ 4.—S.23.
4. Marenich, A.V. Principy lechenija bol'nyh s arterial'­noj gipertenziej (AG) i hronicheskoj serdechnoj nedo­statochnost'ju (HSN). Rol' sutochnogo monitorirovanija arterial'nogo davlenija v sovremennyh uslovijah: obzor literatury / A.V.Marenich.

 

Quality of life of patients with gallstone disease in early postoperative period after the laparoscopic cholecystectomy.

M.F.Yaushev, A.V.Martynov

Department of Phtysiopulmonology of Kazan State Medical University, Kazan, Russia

Abstract. The purpose of this investigation was to estimate a functional status of 160 patients, who underwent laparoscopic cholecystectomy, using quality of life questionnaire (SF-36). There was found a decreasing in all components of SF-36 in first days after surgical operation. Most changes were found in role physical, role emotional, social function and bodily pain. Changes in physical and mental health of SF-36 were minimal. 3—4 week after surgical operation significant positive changes of SF-36 parameters were found with almost full restoration in comparison with healthy group. Most positive dynamics were marked in parameters of role physical and social functioning, general health and bodily pain.

Key words: gallstone disease, laparoscopic cholecystectomy, quality of life.

 

References

1. Dadvani, S.A. Zhelchnokamennaja bolezn' / S.A.Dadvani, P.S.Vetshev, A.M.Shulutko, M.I.Prudkov.—M.: Izdat. dom «Vidar-M», 2000.—144 s.
2. Malkov, I.S. Jendohirurgicheskie vmeshatel'stva pri ostryh zabolevanijah organov brjushnoj polosti: prak­ticheskoe rukovodstvo / I.S.Malkov, R.Sh.Shajmardanov, I.A.Kim // Jendohirurgija Tatarstana.—1996.
3. Novik, A.A. Rukovodstvo po issledovaniju kachestva zhiz­ni v medicine / A.A.Novik, T.I.Ionova.—SPb.:Izdat. dom «Neva», 2002.—320 s.
4. Chikina, S.Ju. Vnelaboratornaja ocenka odyshki i funk­cional'nogo statusa pri bronholegochnoj patologii: (obzor literatury) / S.Ju.Chikina // Pul'monologija.— 2004.—№ 5.—S.98—108.

 

REVIEWS

R.I.Saleyev, S.A.Souslov, R.Sh.Khisamiyev

Medical Unit of MIA in RT, Kazan, Russia

Outpatient treatment of transient ischemic attack

 

The heart rate variability. Method and clinical application.

E.V.Chоukhnin, N.B.Amirov

Department of General Practice of Kazan State Medical University, Kazan, Russia

Abstract. The review is devoted to essence and opportunity of application of a technique вариабельности of a cardiac rhythm at basic diseases in кардиологической to practice (idiopathic hypertensia, myocardial infarction, heart failure), interaction of parts of vegetative nervous system at a various cardial pathology. In the review the modern data of the domestic and foreign researchers on participation of various components of a spectrum to certain to physiological processes are submitted.

Key words: cardiac rhythm, idiopathic hypertensia, myocardial infarction, heart failure.

 

References

1. Vejn, A.M. Vegetativnye rasstrojstva / A.M.Vejn.— OOO «Medicinskoe informacionnoe agenstvo», 1998.— S.64, 66.
2. Variabel'nost' serdechnogo ritma. Standarty izmere­nija, fiziologicheskoj interpretacii i klinicheskogo ispol'zovanija. Rabochaja gruppa Evropejskogo kardiolo­gicheskogo obshhestva i Severo-Amerikanskogo obshhestva stimuljacii i jelektrofiziologii // Vestnik aritmolo-gii.—1995.—Vyp.11. [A.J.Camm (U.K.); Th.Bigger (New York, U.S.A.); G.Breithardt (Munster, Germany); S.Cerutti (Milano, Italy); Ph.Coumel (Paris, France); E.L.Fallen (Hamilton, Canada); H.L.Kennedy (St. Louis, U.S.A.); R.E.Kleiger (St. Louis, U.S.A.); F.Lombardi (Milano, Italy); G.Schmidt (Munchen, Germany)].
3. Jabluchanskij, N.I. Variabel'nost' serdechnogo ritma v sovremennoj klinike / N.I.Jabluchanskij, B.Ja.Kantor, A.V.Martynenko.—2001.
   Podpalov, V.P. Prognosticheskoe znachenie parametrov variabel'nosti ritma serdca kak faktora riska razvi­tija arterial'noj gipertenzii /
4. V.P.Podpalov, A.D.Deev, V.P.Sivakov, L.A.Rozum // Kardiologija.—2006.—№ 1.— S.39—42.
5. Kiselev, A.R. Diagnostika narushenij sokratimosti miokarda na osnove variabel'nosti ritma serdca v hode provedenija velojergometricheskih prob / A.R.Kise­lev, V.I.Gridnev, O.M.Kolizhirina [i dr.] // Kardiolo-gija.—2005.—№ 10.—S.23—26.
6. Abramkin, D.V. Svjaz' izmenenij ChSS vo vremja reflek­tornyh testov s variabel'nost'ju ritma serdca / D.V.Abramkin, I.S.Javelov, N.A.Gracianskij // Kardio-logija.—2004.—№ 8.—S.27—34.
7. Voronin, I.M. Variabel'nost' i spektral'nyj analiz serdechnogo ritma v diagnostike disfunkcij sinusovogo uzla / I.M.Voronin, Ju.A.Govsha, T.A.Istomina, A.M.Belov // Kardiologija.—1999.—№ 10.
8. Rjabykina, G.V. Variabel'nost' ritma serdca / G.V.Rja-bykina, A.V.Sobolev.—1998.—S.173—186.
9. Haspekova, N.B. Reguljacija variativnosti ritma serdca u zdorovyh i bol'nyh s psihogennoj i organicheskoj pa­tologiej mozga: avtoref. dis. ... d-ra med. nauk / N.B.Haspekova.—M., 1996.—48 s.
10. Fomin, F.Ju. Kliniko-diagnostichekoe znachenie issle­dovanija VRS u pozhilyh bol'nyh s arterial'noj giper-tenziej: avtoref. dis. ... / F.Ju.Fomin.—Ivanovo, 2006.
11. Nizamova, G.R. Osobennosti vzaimootnoshenij segmen­tarnyh i suprasegmentarnyh otdelov vegetativnoj ne­rvnoj sistemy u bol'nyh s vegetativnymi krizami i gipertonicheskoj bolezn'ju / G.R.Nizamova, N.R.Hasanov, D.R.Hasanova // Prakticheskaja medicina.—2006.—№ 2.— S.31.
12. Hajutin, V.M. Spektral'nyj analiz kolebanij chastoty serdcebienij: fiziologicheskie osnovy i oslozhnjaju­shhie ego javlenija / V.M.Hajutin, E.V.Lukoshkova // Rossij­skij fiziologicheskij zhurnal im. I.M.Sechenova.— 1999.—T.85, № 7.
13. Kotel'nikov, S.A. Variabel'nost' ritma serdca: pred­stavlenija o mehanizmah / S.A.Kotel'nikov, A.D.Nozdra-chev, M.M.Odinak [i dr.] // Fiziologija cheloveka.— 2002.—T. 28, № 1.—S.130—143.
14. Zhemajtite, D.I. Vegetativnaja reguljacija sinusovogo ritma serdca u zdorovyh i bol'nyh / D.I.Zhemajtite // Analiz serdechnogo ritma.—Vil'njus, 1982.—S.5—22.
15. Kotel'nikov, S.A. Differencial'naja diagnostika sin-kopal'nyh sostojanij s pomoshh'ju spektral'nogo anali­za ritma serdca / S.A.Kotel'nikov, E.A.Mantonin // Sovremennye podhody k diagnostike i lecheniju nervnyh i psihicheskih zabolevanij: materialy konf.—SPb., 2000.—S.463—465.
16. Tarskij, N.A. Osobennosti vremjachastotnogo spektral'­nogo analiza serdechnogo ritma u zdorovyh lic i bol'­nyh s arterial'noj gipertenziej pri provedenii or-tostaticheskoj proby / N.A.Tarskij, V.N.Shvalev, S.Ju.­Saltykov [i dr.] // Kardiologija.—2000.—№ 4.
17. Dovgalevskij, P.Ja. Pokazateli variabel'nosti ritma serdca u bol'nyh ishemicheskoj bolezn'ju serdca v za­visimosti ot tjazhesti ateroskleroza koronarnyh arte­rij (po dannym selektivnoj koronarografii) i funk­cional'nogo klassa stenokardii / P.Ja.Dovgalevskij, O.K.Rybak, N.V.Furman // Kardiologija.—2002.—№ 9.
18. Javelov, I.S. Faktory, svjazannye s nizkoj variabel'­nost'ju ritma serdca, ocenennoj za korotkoe vremja v pokoe v rannie sroki infarkta miokarda / I.S.Javelov, E.E.Travina, N.A.Gracianskij // Kardiologija.—2001.— № 8.
19. Boldueva, S.A. Psihologicheskie osobennosti i varia­bel'nost' serdechnogo ritma u vnezapno umershih i vy­zhivshih bol'nyh infarktom miokarda / S.A.Boldueva, O.V.Trofimova, V.S.Zhuk // Terapevticheskij arhiv.— 2006.—№ 12.
20. Latfullin, I. Variabel'nost' ritma serdca i ocenka vlijanija selektivnyh b-blokatorov v ostrom periode infarkta miokarda / I.Latfullin, G.Ishmurzin // Vrach.—2001.—№ 1.—S.24.
21. Shal'nova, S.A. Chastota pul'sa i smertnost' ot serdech­no-sosudistyh zabolevanij u rossijskih muzhchin i zhen­shhin. Rezul'taty jepidemiologicheskogo issledovanija / S.A.Shal'nova, A.D.Deev, R.G.Oganov [i dr.] // Kardiolo-gija.—2005.—№ 10.—S.45—50.
22. Ibatov, A.D. Kardiovaskuljarnye testy i pokazateli VRS u bol'nyh s PIKS i razlichnym funkcional'nym klas­som serdechnoj nedostatochnosti / A.D.Ibatov, E.A.Syr-kina, A.L.Syrkin, O.P.Fesechenko // Zhurnal serdechnoj nedostatochnosti.—2003.—№ 4.
23. Parnes, E.Ja. Pokazateli variabel'nosti ritma serd­ca vo vremja velojergometricheskoj proby / E.Ja.Parnes, E.V.Koshkina, M.Ja.Krasnosel'skij // Kardiologija.— 2003.—№ 8.
24. Zaharova, N.Ju. Fiziologicheskie osobennosti varia­bel'nosti ritma serdca v raznyh vozrastnyh gruppah / N.Ju.Zaharova, V.P.Mihajlov // VA.— 2003.—№ 31.— S.37—40.
25. Morozov, P. Narushenie reakcii so storony chastoty serdechnyh sokrashhenij mozhet svidetel'stvovat' o na­lichii ishemicheskoj bolezni serdca / P.Morozov // Rus. med. zhurn.—2004.—№ 4.
26. Tatarchenko, I.P. Klinicheskaja ocenka pokazatelej vari­abel'nosti ritma serdca u bol'nyh s razlichnymi for­mami ishemicheskoj bolezni serdca / I.P.Tatarchenko, N.V.Pozdnjakova, O.I.Morozova, V.A.Beljaev // VA.— 1999.—№ 12.—S.20—25.
27. Chakko, S. Alteration in heart rate variability and its circadian rhythm in hypertensive patients with left ventricular hyperthrophy free of coronary artery disease / S.Chakko, R.F.Malingtapand, H.V.Huikuri // Am. Heart J.—1993.— Vol.12, № 6.—R.1363—1372.
28. Huikuri, H.V. Heart rate variability in systemic hypertension / H.V.Huikuri // Am. J. Cardiology.—1996.—Vol.15.—R.1073— 1077.
29. Mancia, G. Variability della frequenza cardiaca nel paziente iperteso: implicazioni cliniche e fisiopatologiche / G.Mancia, M.Di-Rienzo, G.Parati // Ann. Ital. Vet. Int.—1994.—Oct 9.— R.21—26.
30. Eckoldt, K. Spectral analylis of the sinus arrhythmia in cardiac patients.10th internat / K.Eckoldt, H.Cammann, U.Menthey // Congr. Electrocardiology.—Bratislava, 1983.—P.68.
31. Dabrowska, B. Heat rate variability before suden blood pressure elevation or complex cardiac arrhitmias in pheocyromacytoma / B.Dabrowska // J. Hypertens.— 1996.—Vol.10, № 1.—R.43—50.
32. Nolan, J. Cardiac parasympathetic activity in severe uncomplicated coronary artery disease / J.Nolan, A.D.Flapan, J.Reid // Br. J.—1994.—Vol.71.—№ 6.—R.515—520.
33. Lauer, M.S. Impaired heart rate response to graded exercise. Prognostic implications of chronotropic incompetence in the Framingham Heart Study / M.S.Lauer, P.M.Okin, M.G.Larson [et al.] // Circulation.—1996.—№ 93.—R.1520—1526.
34. Zipes, D.P. Influence of myocardial ischemia and infarction on automatic innervation of heart / D.P.Zipes // Circulation.— 1990.—№ 82.—R.1095—1105.
35. Neihen, S. Relation detweenrate variability early after acute myocardial infarction and long-term mortality / S.Neihen, R.Stevenson, B.Marchant // Am. J. Cardiol.—1994.—№ 73.— R.653—657.
36. Hartikeinen, J. Sympletic reinnervation after acute myocardial infarction / J.Hartikeinen, J.Kuikha, M.Montysaari // Am. J. Cardiol.—1996.—№ 77.—R.5—9.
37. Bigger, J.T. Time course of recovery of heart period variability after myocardial infarction / J.T.Bigger, J.L.Fleiss, L.M.Rolnitzky [et al.] // J. Am. Coil. Cardiol.—1991.—№ 18.— R.1643—1649.
38. Lombardi, F. Heart rate variability as an index of sympathovagal interaction after myocardial infarction / F.Lombardi, G.Sandrone, S.Pempruner [et al.] // Am. J. Cardiol.—1987.—№ 60.—R.1239—1245.
39. Lombardi, F. Circadian variation of spectral indices of heart rate variability after myocardial infarction / F.Lombardi, G.Sandrone, A.Mortara [et al.] // Am. Heart. J.—1992.—№ 123.—R.1521— 1529.
40. Bigger, J.T.Jr. Frequency domain measures of heart period variability and mortality after myocardial infarction / J.T.Jr.Bigger, J.L.Fleiss, R.C.Steinman [et al.] // Circulation.—1992.—№ 85.—R.164—171.
41. Malliani, A. Power spectral analysis of heart rate variability: a tool to explore neural regulatory mechanisms / A.Malliani, F.Lombardi, M.Pagani // Br. Heart. J.—1994.—№ 71.—R.1—2.
42. Malik, M. Components of heart rate variability. What they really mean and what we really measure / M.Malik, A.J.Camm // Am. J. Cardiol.—1993.—№ 72.—R.821—822.
43. Schwartz, P.J. Autonomic mechanisms and sudden death.New insights from the analysis of baroreceptor reflexes in conscious dogs with and without a myocardial infarction / P.J.Schwartz, E.Vanoli, M.Stramba-Badiale [et al.] // Circulation.—1988.—№ 78.—R.969—979.
44. Malliani, A. A sympathetic reflex elicited by experimental coronary occlusion / A.Malliani, P.J.Schwartz, A.Zanchetti / / Am. J. Physiol.—1969.—№ 217.—R.703—709.
45. Schwartz, P.J. A cardio-cardiac sympatho-vagal reflex in the cat / P.J.Schwartz, M.Pagani, F.Lombardi [et al.] // Circ. Res.—1973.—№ 32.—R.215—220.
46. Malliani, A. Cardiovascular sympathetic afferent fibers / A.Malliani // Rev. Physiol. Biochem. Pharmacol.—1982.— № 94.—R.11—74.
47. Malliani, A. Power spectral analysis of heart rate variability: a tool to explore neural regulatory mechanisms / A.Malliani, F.Lombardi, M.Pagani // Br. Heart. J.—1994.—№ 71.—R.1— 2.
48. Malliani, A. Cardiovascular neural regulation explored in the frequency domain / A.Malliani, M.Pagani, F.Lombardi, S.Cerutti // Circulation.—1991.—№ 84.—R.1482—1492.
49. Kamath, M.V. Power spectral analysis of heart rate variability: a noninvasive signature of cardiac autonomic function / M.V.Kamath, E.L.Fallen // Crit. Revs. Biomed. Eng.—1993.— № 21.—R.245—311.
50. Appel, M.L. Beat to beat variability in cardiovascular variables: Noise or music? / M.L.Appel, R.D.Berger, J.P.Saul [et al.] // J. Am. Coil. Cardiol.—1989.—№ 14.—R.1139— 1148.
51. Casolo, G. Decreased spontaneous heart rate variability on congestive heart failure / G.Casolo, E.Balli, T.Taddei // Am. J. Cardiol.—1989.—№ 64.—R.1162—1167.
52. Kienzle, M.G. Clinical hemodynamic and sympathetic neural correlates of heart rate variability in congestive heart failure / M.G.Kienzle, D.W.Ferguson, C.L.Birkett [et al.] // Am. J. Cardiol.—1992.—№ 69.—R.482—485.
53. Flapan, N.J. Decreased cardiac parasimpathetic activity in chronic heart failure and its relation the left ventricular function / N.J.Flapan, S.Capewell // Ibit.—1992.—Vol.67, № 6.—R.482—485.
54. Saul, J.P. Assesment of autonomic regulation in chronic congestiv heart failure by heart rate specral analisis / J.P.Saul, Y.Arai, R.D.Berger // Am. J. Cardiol.—1988.— № 61.—R.1292—1299.
55. Fei, L. Heart rate variability and its relation to ventricular arrhythmias in congestive heart failure / L.Fei, P.J.Keeling, G.S.Gill // Br. Heart J.—1994.—№ 71.—R.322—328.
56. Tsuji, H. Reduced heart rate variability and mortality risk in an elderly cohort: The Framingham Study / H.Tsuji, F.J.Venditti, E.S.Manders [et al.] // Circulation.—1994.— № 90.—R.878—883.
57. Hartikeinen, J. Distingtion between arrythmic and non-arrythmic mortality after acute myocardial ihfarction based on heart rate variability and left ventricular ejection fraction / J.Hartikeinen, M.Malik, A.Staunton // Eur. Heart J.— 1995.—№ 16.—P.431.
58. Loriccho, M.L. Heart rate variability, coronary morphology and prognostic unstable angina / M.L.Loriccho, A.Borghi // Eur. Heart J.—1995.—№ 16.—P.471.
59. Akselrod, S. Power spectrum analysis of heart rate fluctuation: a quantitative probe of beat to beat cardiovascular control / S.Akselrod, D.Gordon, F.A.Ubel [et al.] // Science.—1981.— № 213.—R.220—222.
60. Pomeranz, M. Assessment of autonomic function in humans by heart rate spectral analysis / M.Pomeranz, R.J.Macaulay, M.A.Caudill // Am. J. Physiol.—1985.—№ 248.—R.151—153.

 

Clinical and functional characteristic of cardiorenal continuum.

A.G.Scherbakova, O.N.Sigitova, E.V.Arkhipov

Department of General Practice of Kazan State Medical University, Kazan, Russia

Abstract. Cardio-vascular diseases are essential cause of death of patents with chronic renal insufficiency, and they are often present in chronic renal disease and less in general population. Cardio-vascular diseases are forming under the influence of traditional risk factors, but their incidence in chronic renal disease is more. Non-traditional factors which bound from chronic renal disease also make great contribution. On other side, kidneys in cardio-vascular diseases usually are target organs. So, relationship between pathology of cardio-vascular system and kidneys is constructing in mechanism of converse communication and formation of cardio-renal continuum.

Key words: chronic renal failure, chronic renal disease, cardio-vascular diseases, cardio-renal continuum.

 

References

1. Ageev, F.T. Diastolicheskaja disfunkcija kak projavlenie remodelirovanija serdca / F.T.Ageev, A.G.Ovchinnikov // Serdechnaja nedostatochnost'.—2002.—T.3, № 4(14).— S.190—195.
2. Anemija i diastolicheskaja funkcija levogo zheludochka u bol'nyh s dodializnoj hronicheskoj pochechnoj nedosta­tochnost'ju / A.M.Shutov, E.S.Kulikova, T.N.Ivashkina, N.I.Kondrat'eva // Nefrologija i dializ.—2001.—T.3, № 4.—S.422—426.
3. Belenkov, Ju.N. Medikamentoznye puti uluchshenija bol'­nyh hronicheskoj serdechnoj nedostatochnost'ju: dannye dvadcatiletnego nabljudenija / Ju.N.Belenkov, V.Ju.Ma-reev.—M.: INSAJT, 1997.—198 c.
4. Belenkov, Ju.N.Remodelirovanie levogo zheludochka: kompleksnyj podhod / Ju.N. Belenkov // Serdechnaja ne-dostatochnost'.—2002.—T.3, № 4(14).—S.161—163.
5. Bikbov, B.T. O sostojanii zamestitel'noj terapii bol'­nyh s hronicheskoj pochechnoj nedostatochnost'ju v Ros­sijskoj Federacii v 2001 godu. (Otchet po dannym Ros­sijskogo registra) / B.T.Bikbov, N.A.Tomilina // Nefro­logija i dializ.—2004.—№ 1.—S.4—42.
6. Vasjuk, Ju.A. Vozmozhnosti i ogranichenija jehokardiogra-ficheskogo issledovanija v ocenke remodelirovanija levogo zheludochka/ Ju.A.Vasjuk // Serdechnaja nedostatoch-nost'.—2003.—T. 4, № 2(18).—S.107—110.
7. Zemchenkov, A.Ju. «K/DOKI» obrashhaetsja k istokam hro­nicheskoj pochechnoj nedostatochnosti / A.Ju.Zemchenkov, N.A.Tomilina // Nefrologija i dializ.—2004.—T.6, № 3.—S.204—220.
8. Ol'binskaja, L.I. Patogenez i sovremennaja farmako­terapija hronicheskoj serdechnoj nedostatochnosti / L.I.Ol'binskaja, S.B.Ignatenko // Serdechnaja nedosta-tochnost'.—2002.—T.3,№ 2(12).—S.87—91.
9. Pervye rezul'taty nacional'nogo jepidemiologichesko­go issledovanija — jepidemiologicheskoe obsledovanie bol'nyh HSN v real'noj praktike (po obrashhaemosti) — JePOHA-O-HSN / Ju.N.Belenkov, V.Ju.Mareev, F.T.Ageev, M.O.Danieljan // Serdechnaja nedostatochnost'.—2003.— T.4, № 3(19).—S.116—120.
10. Problema serdechno-sosudistyh zabolevanij pri hro­nicheskoj pochechnoj nedostatochnosti / N.A.Tomilina, G.V.Volgina, B.T.Bikbov, I.G.Kim // Nefrologija i dia-liz.—2003.—T.5, № 1.—S.53—59.
11. Remodelirovanie levogo zheludochka u bol'nyh s hroni­cheskoj pochechnoj nedostatochnost'ju bez vyrazhennoj ane­mii / A.M.Shutov, T.N.Ivashkina, E.S.Kulikova, N.I.Kon­drat'eva // Nefrologija.—2000.—№ 4(1).—S.44—47.
12. Serdechnaja nedostatochnost' u bol'nyh s hronicheskoj pochechnoj nedostatochnost'ju / G.I.Storozhakov, N.A.Tomi­lina, V.Ju.Shilo, G.E.Gendlin // Serdechnaja nedostatoch-nost'.—2005.—T.6, № 3.—S.100—104.
13. Smirnov, A.V. Kardiorenal'nyj kontinuum: patogene­ticheskie osnovy preventivnoj nefrologii / A.V.Smir­nov, V.A.Dobronravov, I.G.Kajukov // Nefrologija.— 2005.—T.3.—S.8—12.
14. Tareeva, I.E. Puti tormozhenija neimmunnogo progres-sirovanija nefritov / I.E.Tareeva, I.M.Kutyrina, N.I.Neverov // Klinicheskaja medicina.—1995.—№ 3.— C.80—83.
15. Han, H. Arterial'naja gipertenzija i pochki / H.Han, A.M.Shutov // Nefrologija i dializ.—2002.—T. 4, № 8.— S.217—219.
16. Hronicheskaja serdechnaja nedostatochnost' u bol'nyh s hronicheskoj bolezn'ju pochek / A.M.Shutov, N.Ja.Marder, G.A.Hamidullina [i dr.] // Nefrologija i dializ.— 2005.—T. 7, № 2.—S.140—144.
17. Absence of association or genetic linkage between angiotensin-converting enzyme gene and left ventricular mass / K.Lindpaintner, M.Lee, M.G.Larson [et al.] // N. Engl. Med.—1996.—Vol. 334.—P.1023—1028.
18. Angiotensin II type 1 receptor A/C1166 polymorphism: relationship with blood pressure and cardiovascular structure / M.Castellano, M.L.Muiesan, M.Bescbi [et al.] // Hypertention.—1996.—Vol.28.—P.1076—1080.
19. Baseline blood pressure and other variables influencing survival on hemodialysis of patients without overt cardiovascular disease / J.J.G.De Lima, M.L.C.Vieira, H.Abensur, M.Krieger // Nephrol. Dial. Transplant.—2001.— Vol.16.—P.793—797.
20. Beto, J.A. Interventions for Other Risk Factors: Tobacco Use, Physical Inactivity, Menopause, and Homocysteine / J.A.Beto, V.K.Bansal // Am. J. Kidney Dis.—1998.—Vol.32, suppl.5.—P.112—118.
21. Brown, M.A. Hypertension in human renal disease / M.A.Brown, J.A.Whitwort // J. Hypertens.—1992.—Vol.10.— P.701—712.
22. Cardiac hypertrophy, hypertrophic cardiomyopathy and hyperparathyroidism — an association / G.Symons, F.Fortune, R.A.Greenbaum, P.Dandona // Br. Heart J.— 1985.—Vol.54.—P.539—542.
23. Cardiovascular disease and mortality in a community-based cohort with mild renal insufficiency / B.F.Culleton, M.G.Larson, P.W.Wilson [et al.] // Kidney Int.—1999.— Vol.56.—P.2214—2219.
24. Cardiovascular disease in end-stage renal disease patients / A.J.Collins, L.Shuling, Z.Jennie, C.Herzog // Am. J. Kidney Dis.—2001.—Vol.38 (4), suppl.1.—P.26—29.
25. Cassery, L.M. Congestive heart failure and its management in end-stage renal failure / L.M.Cassery, M.M.Givertz // Oxford Clinical Nephrology Series.—2000.—P.289—317.
26. Cohen-Solar, A. Left ventricular diastolic function: pathophysiology, diagnosis and treatment / A.Cohen-Solar // Nephrol. Dial. Transplant.—1998.—Vol.13, suppl.4.— P.3—5.
27. Congestive heart failure in dialysis patients: Prevalence, incidens, prognosis and risk factors / J.D.Harnett, R.N.Foley, G.M.Kent [et al.] // Kidney Int.—1995.— Vol.47.—P.884—890.
28. Dahlof, B. Reversal of left ventricular hypertrophy in hypertensive patients. A meta-analysis of 109 treatment studies / B.Dahlof, K.Pennert, L.Hansson // Am. J. Hypertens.—1992.—Vol.5.—P.95—110.
29. Determinants of left ventricular hypertrophy and systolic dysfunction in chronic renal failure / S.C.Greaves, C.D.Gamble, J.E.Collins [et al.] // Am. J. Kidney Dis.— 1994.—Vol.24 (5).—P.768—777.
30. Executive Abstract of The Third Report of The National Colesterol Edication Program (NCEP) Expert Panel on Detection Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III) / J. Am. Med. Assoc.—2001.—Vol.285.—P.2486—2497.
31. Foley, R.N. Epidemiology of cardiovascular disease in chronic renal failurec / R.N.Foley, P.S.Parfrey, M.Sarnak // Am. J. Kidney Dis.—1998.—Vol.32, suppl.3.—P.12—19.
32. Harnett, J.D. Left ventricular dysfunction in dialysis patients / J.D.Harnett, P.S.Parfrey; ed. W.L.Henrich // Principles and practice of dialysis.—Baltimore: MD Williams, Willkins, 1995.—P.170—180.
33. Herzog, C.A. Poor long-term survival after acute myocardial infarction among patients on long-term dialysis / C.A.Herzog, J.Z.Ma, A.J.Collins // N. Engl. J. Med.— 1998.—Vol.339.—P.799—805.
34. K/DOQI. Klinicheskie prakticheskie rekomendacii po hronicheskomu zabolevaniju pochek: ocenka, klassifika­cija i stratifikacija: Ch. 7. Stratifikacija riska pro-gressirovanija zabolevanija pochek i razvitija serdechno­sosudistoj patologii. Polozhenie 15. Svjaz' hroniches­kogo zabolevanija pochek s serdechno-sosudistoj patolo­giej: [Jelektronnyj resurs].—http://www.dialysis.ru/ standard/doqi_ckd/g15.htm, svobodnyj.
35. Kassiske, B.L. Cardiovascular disease after renal trans­plantation / B.L.Kassiske, C.Guijarro, Z.A.Massy // J. Am. Soc. Nephrol.—1996.—Vol.7.—P.158—165.
36. Keane, W.F. Proteinuria, albuminuria, risk, assessment, detection, elimination (PARADE): A position paper of the National Kidney Foundation / W.F.Keane, G.Eknoyan // Am. J. Kidney Dis.—1999.—Vol.33.—P.1004—1010.
37. Keane, W.F. Proteinuria: Its clinical importance and role in progressive renal disease / W.F.Keane // Am. J. Kidney Dis.—2000.—Vol.35, suppl.1.—P.S97—S105.
38. Level of kidney function as a risk factors for atherosclerotic cardiovascular outcomes in the community / G.Majunath, H.Tighionart, H.Ibrahim [et al.] // J. Am. Coll. Cardiol.— 2003.—Vol.41.—P.47—55.
39. Levin, A. Prevalent left ventricular hypertrophy in the predialysis population: Identifying opportunities for intervention / A.Levin, J.Singer, C.R.Thompson // Am. J. Kidney Dis.—1996.—Vol.27.—P.347—354.
40. Levy, D. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study / D.Levy, R.J.Garrison, D.D.Savage // N. Engl. J. Med.—1990.—Vol.322.—P.1561—1566.
41. Long-term survival in renal transplant recipients with graft function / A.O.Ojo, J.A.Nanson, R.A.Wolfe [et al.] // Kidney Int.—2000.—Vol.57.—P.307—313.
42. Luke, R.G. Chronic renal failure: a vasculopathic state / R.G.Luke // N. Engl. J. Med.—1998.—Vol.339.—P.841— 843.
43. Majunath, G. Level of kidney function as a risk factors for cardiovascular outcomes in the elderly / G.Majunath, H.Tighionart, F.Corest // Kidney Int.—2003.—Vol.63.— P.1121—1129.
44. Massy, Z.A. Importance of homocysteine, lipoprotein (a), and non-classical cardiovascular risk factors (fibrinogen, and advanced glycation end products) for atherogenesis in uremic patients / Z.A. Massy // Nephrol. Dial. Transplant.— 2000.—Vol.15, suppl.5.—P.81—91.
45. National High Blood Pressure Education Program Working Group. 1995 Update of the working group reports on chronic renal failure and renovascular hypertension // Arch. Intern. Med.—1995.—Vol.156.—P.1938—1947.
46. Parfrey, P.S. The clinic epidemiology of cardiac disease in chronic renal failure / P.S.Parfrey, R.N.Foley // J. Amer. Soc. Nephrol.—1997.—Vol.10.—P.1—18.
47. Relationship between parathyroid hormone and left ventricular mass in moderate essential hypertention / D.Duprez, F.Bauwens, M.De Buyzere [et al.] // J. Hypertens.—1991.—Vol.9, suppl.6.—P.116—117.
48. Report from the 1995 core indicators for peritoneal dialysis study group / M.V.Rocco, M.J.Flanagan, S.Beaver [et al.] / / Am. J. Kidney Dis.—1997.—Vol.30.—P.165—173.
49. Ross, R. Aterosclerosis — An Inflammatory Disease / R.Ross // New Engl. Med.—1999.—Vol.340, № 2.—P.115—126.
50. Rostand, S.G. Cardiac disease in dialysis patients / S.G.Rostand, E.A.Rutsky // Clinical dialysis.—New York, 1995.—P.652—698.
51. Schluter, K.D. Trophic effects of catecholamines and parathyroid hormone on adult ventricular cardiomyocytes / K.D.Schluter, H.M.Piper // Am. J. Physiol.—1992.— Vol.263.—P.1739—1746.
52. Secondary hyperparathyroidism and cardiac hypertrophy in hemodialysis patients / G.M.London, M.Vernerejoul, F.Fabiani [et al.] // Kidney Int.—1987.—Vol.32.—P.900— 907.
53. Study Group Diabetes and Uremia: Serum lipids predict cardiac death in diabetic patients on maintenance hemodialysis: Results of a prospective study / W.Tschope, M.Koch, V.Thomas [et al.] // Nephron.—1993.— Vol.64.— P.354—358.
54. The association of serum lipids and inflammatory biomarkers with renal function in men with type II diabets / J.Lin, F.B.Hu, E.B.Rimm [et al.] // Kidney Int.—2006.— Vol.69 (2).—P.336—342.
55. Tingleff, J. Prevalence of left ventricular hypertropty in hypertensive population / J.Tingleff, M.Munch // Eur. Heart. J.—1996.—Vol.17.—P.143—149.
56. Wizemann, V. Coronary artery disease in dialysis patients / V. Wizemann // Nephron.—1996.—Vol.74.—P.642—651.

 

LECTURES

Chronic renal disease and chronic renal failure — current approaches to the terms, classification and diagnosis.

O.N.Sigitova

Department of General Practice of Kazan State Medical University, Kazan, Russia

Abstract. The concept of the term «chronic renal disease» is disclosed, the classification is listed, the switch to the new classification, which was approved by the VI-th congress of the Russian Nephrologists Society in 2006 y. and recommended for general practice in Russian Federation instead of the term «chronic renal failure», the methods of diagnosis are listed.

Key words: chronic renal disease, terms, classification, diagnosis.

 

References

1. Bondarenko, B.B. Jepidemiologija i techenie hroniches­koj pochechnoj nedostatochnosti / B.B.Bondarenko, E.I.Ki­seleva; red. prof. S.I.Rjabov // Hronicheskaja pochechnaja nedostatochnost'.—L.: Medicina, 1976.—S.34—50.
2. Ermolenko, V.M. Hronicheskaja pochechnaja nedostatochnost' / V.M.Ermolenko; red. prof. I.E.Tareeva.—M.: Medici­na, 2000.—C.596—698.
3. Lavil', M. Rol' arterial'noj gipertonii v progressi-rovanii pochechnoj nedostatochnosti, jeffektivnost' an-tigipertenzivnoj terapii / M.Lavil' // Nefrologija.— 2000.—T.4, № 1.—S.119—121.
4. Muhametzjanov, I.Sh. Kompleksnaja ocenka potrebnosti i obespechennosti v zamestitel'nom lechenii bol'nyh s terminal'noj pochechnoj nedostatochnost'ju / I.Sh.Muha-metzjanov // Nefrologija i dializ.—2001.—T.3, № 1.— S.17—24.
5. Muhin, N.A. Hronicheskie progressirujushhie nefropa-tii i obraz zhizni sovremennogo cheloveka / N.A.Muhin, I.M.Balkarov, S.V.Moiseev [i dr.] // Terapevt. arhiv.— 2004.—№ 9.—S.5—11.
6. Nikolaev, A.Ju. Lechenie pochechnoj nedostatochnosti / A.Ju.Nikolaev, Ju.S.Milovanov.—M.: Medicina, 1999.— 362 s.
7. O sostojanii zamestitel'noj pochechnoj terapii HPN v Rossijskoj Federacii v 1998 g. [Ezhegodnyj otchet po dannym Rossijskogo registra] // Nefrologija i dia-liz.—2000.—T.2, № 1—2.—S.4—24.
8. Sigal, V.E. Sostojanie zamestitel'noj pochechnoj tera­pii v Respublike Tatarstan: dostizhenija i problemy / V.E.Sigal // Mediko-farmacevticheskij vestnik Tatar-stana.—2006.—№ 31 (119).—S.6.
9. Smirnov, A.V. Jepidemiologija i social'no-jekonomiches­kie aspekty hronicheskoj bolezni pochek / A.V.Smirnov, V.A.Dobronravov, I.G.Kajukov [i dr.] // Nefrologija.— 2006.—T.10, № 1.—S.7—13.
10. Smirnov, A.V. Sovremennye podhody k zamedleniju pro-gressirovanija bolezni pochek / A.V.Smirnov, A.M.Esa-jan, I.G.Kajukov [i dr.] // Nefrologija.—2003.—T.8, № 3.— S.89—99.
11. Tomilina, N.A. Jepidemiologija hronicheskoj pochechnoj nedostatochnosti i novye podhody k klassifikacii i ocenke tjazhesti hronicheskih progressirujushhih zabole­vanij pochek / N.A.Tomilina, B.T.Bikbov // Terapevtiches­kij arhiv.—2005.—№ 6.
12. Coresh, V. Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey / V.Coresh, B.C.Astor, T.Green [et al.] // Am. J. Kidney Dis.—2003.— Vol.41(1).—P.1—12.
13. Fester, P. Determinants of cardiorenal damage progression in normotensive and never—treated hypertensive subjects / P.Fester, J.Ribstein, G.du Cailar, A.Mimran // Kidney Int.— 2005.—Vol.67 (5).—P.1974—1979.
14. K/DOQI: Klinicheskie prakticheskie rekomendacii po hronicheskomu zabolevaniju pochek: ocenka, klassifika­cija i stratifikacija: [Jelektronnyj resurs, 2002].— http://www.dialysis.ru/standard/doqi—ckd/g7.htm
15. Munter, P. Plasma lipids and risk of developing renal dysfunction / P.Munter, J.Coresh, J.C.Smith [et al.] // Kidney int.—2000.—Vol.58 (1).—P.293—301.
16. Pinto-Sietsma, S.J. Smoking is related to albuminuria and abnormal renal funtion in nondiabetic persons / S.J.Pinto-Sietsma, J.Mulder, W.M.Janssen [et al.] // Ann. Intern. Med.—2000.—Vol.17, suppl.133 (8).—P.585—591.
17. Tanaka, H. Metabolic syndrome and chronic kidney disease in Okinawa, Japan / H.Tanaka [et al.] // Kidney Int.—2006.— Vol.69 (2).—P.369—374.
18. Schiepati, A. Renal disease as a public health problem. Epidemiology, social and economic implications / A.Schiepati, G.Remmuzi // Kidney Int.—2005.—Vol.68.— P.7—10.

 

Methodological basis of contemporary rehabilitation (clinical lecture).

I.A.Bоurenina

Department of Rehabilitology and Sports Medicine of Kazan State Medical Academy, Kazan, Russia Clinical Hospital of Medico-Sanitary Department of Ministry of Internal Affairs of Republic of Tatarstan, Kazan, Russia

Abstract. The aim of this article is to acquaint attending physicians of different specialties with the meaning of rehabilitation, its aim and tasks and also with the main directions (aspects) and principles of medical rehabilitation.

Key words: rehabilitation, restorative medicine, medical-social adjustment, individual rehabilitation program.

 

References

1. Auhadeev, Je.I. Mezhdunarodnaja klassifikacija funk­cionirovanija, ogranichenij zhiznedejatel'nosti i zdo­rov'ja, rekomendovannaja VOZ, — novyj jetap razvitija reabilitologii / Je.I.Auhadeev // Kazanskij medicin­skij zhurnal.—2007.—№ 1, T.88.—S.5—9.
2. Auhadeev, Je.I. Novyj jetap v metodologicheskom raz­vitii vosstanovitel'nogo lechenija, mediko-social'­noj jekspertize i reabilitacii bol'nyh i invalidov / Je.I.Auhadeev // Vertebronevrologija.—2006.—T.13, № 1.—2.—S.32—37.
3. Belova, A.N. Nejroreabilitacija / A.N.Belova // Ruko­vodstvo dlja vrachej.—M.: Antidor, 2002.—736 s.
4. Belova, A.N. Shkaly, testy i oprosniki v medicinskoj reabilitacii / A.N.Belova, O.N.Shhepetova.—M.: Anti-dor, 2002.—440 s.
5. Bogoljubov, V.M. Medicinskaja reabilitacija (rukovod­stvo): v 3 t. / V.M.Bogoljubov; pod red. V.M.Bogoljubo-va.—M., 2007.
6. Epifanov, V.A. Medicinskaja reabilitacija: rukovod­stvo dlja vrachej / V.A.Epifanov.—M.: MEDpress-in-form, 2005.—328 s.
7. Zajcev, V.P. Psihologicheskaja reabilitacija bol'nyh / V.P.Zajcev // Medicinskaja reabilitacija: rukovodstvo / pod red. V.M.Bogoljubova.—M., 2007.—T.1.—S.531—568.
8. Kljachkin, L.M. Medicinskaja reabilitacija bol'nyh s za­bolevanijami vnutrennih organov: rukovodstvo dlja vra­chej / L.M.Kljachkin, A.M.Shhegol'kov.—M.: Medicina, 2000.—325 s.
9. Mezhdunarodnaja nomenklatura narushenij, ogranichenij zhiznedejatel'nosti i social'noj nedostatochnosti.— M., 1994.—108 s.
10. Spravochnik po mediko-social'noj jekspertize i reabi­litacii / pod red. M.V.Korobova, V.G.Pomnikova.— 2-e izd., ispr. i dop.—SPb.: Gippokrat, 2005.—856 s.
11. Fizicheskaja reabilitacija: uchebnik dlja akademij i in-tov fiz. kul'tury/ S.N.Popov, N.M. Valeev, L.S.Zaharo­va [i dr.]; pod obshh. red. S.N.Popova.—Rostov n/D.: Fe­niks, 1999.—604 s.
12. Junusov, F.A. Organizacija mediko-social'noj reabi­litacii za rubezhom / F.A.Junusov, V.Gajger, Je.Mikus.— M.: Obshherossijskij obshhestvennyj fond «Social'noe razvitie Rossii», 2004.—310 s.

 

BRIEF ARTICLES

Occurrence and peculiarities of hypertensive syndrome and cardio-vascular diseases risk factors in employees of Ministry of Internal Affairs/ Ministry of extraordinary situations working in traffic inspectorate and anti-fire service

N.B.Amirov, A.A.Vizel, M.V.Potapova, F.I.Ishkineyev, E.B.Frolova, E.F.Merikova, V.V.Iskandarova, Ju.A.Afanasyeva, O.R.Sokolova, R.G.Khousnoutdinova

Kazan State Medical University, Russia Medical Unit of MIA in RT, Kazan, Russia

 

Peculiarities of bronchoobstructive syndrome in employees of Ministry of Internal Affairs/Ministry of extraordinary situations working in traffic inspectorate and anti-fire service

A.A.Vizel, N.B.Amirov, M.V.Potapova, F.I.Ishkineyev, E.B.Frolova, E.F.Merikova, V.V.Iskandarova, Ju.A.Afanasyeva, O.R.Sokolova, R.G.Khousnoutdinova

Kazan State Medical University, Russia Medical Unit of MIA in RT, Kazan, Russia

 

Ophthalmologist and venereologist joint work experience in the case of eyes Chlamydia infections

L.K.Bounakova, S.N.Kharitonova, E.V.Faizoullina

Medical Unit of MIA in RT, Kazan, Russia Kazan State Medical University, Russia

Health level of internal affairs employees: perspectives of study

L.K.Bounakova, M.V.Potapova, E.V.Faizoullina

Medical Unit of MIA in RT, Kazan, Russia Kazan State Medical University, Russia

Assessment of health resources in patients with psoriasis

L.K.Bounakova, E.V.Faizoullina, F.G.Sadykova

Medical Unit of MIA in RT, Kazan, Russia Kazan State Medical University, Russia

Otomycosis in patients: system of diagnostics, treatment and rehabilitation

L.K.Bounakova, V.V.Egorova, E.V.Faizoullina

Medical Unit of MIA in RT, Kazan, Russia Kazan State Medical University, Russia

Structural-functional changes in pancreas and its bloodstream in case of early experimental ischemia

R.K.Kadyrov

Kazan State Medical University, Russia

DISCUSSIONS

Etiology, pathogenesis, principles of diagnostics and treatment of vascular insufficiency.

B.M.Miroljubov

Department of surgery with courses of oncology, anesthesiology and reanimatology of Kazan state medical University, Kazan, Russia

Abstract. Nowadays the vascular heart diseases are the most common diseases in the world. However it must be admitted that while treating the patients with essentially common pathology specialists in different areas speak «different languages». It’s impossible to ignore the fact that every organ including a heart has blood vessels carrying blood away from or towards the organ. Both impulsive and insidious blockade and loss of vessel wall integrity leads to a vascular insufficiency in the form of the diverse pathology that fall within subspecialists’ sphere of competence. This led us to the idea of systematizing the vascular insufficiency. This article first represents the system of vascular insufficiency in the form of currently exist and applied classifications and propose the system of classifications that might be applied in the nearest future. It proves the necessity to unify the diagnosis structure for different specialties and classify treatment methods and facilities referring to etiology, pathogenesis and symptomatology of a disease.

Key words: vascular insufficiency, system, classification, organ.

References

1. Vedenskij, A.N. Varikoznaja bolezn' / A.N.Vedenskij.— L.,1983.
2. Vedenskij, A.N. Posttromboticheskaja bolezn' / A.N.Ve-denskij.—L.,1986.
3. Miroljubov, B.M. Novye napravlenija v angiologii i sosudistoj hirurgii / B.M.Miroljubov, L.M.Mirolju-bov, V.E.Mamaev. I.M.Ignat'ev.—1995.—S.100.
4. Miroljubov, B.M. Progress i problemy v lechenii zabo­levanij serdca i sosudov / B.M.Miroljubov.—1997.— S.259.
5. Miroljubov, B.M., Miroljubov L.M. // Annaly hirur-gii.—2002.—№ 6.—S.64—66.
6. Miroljubov, B.M. Sosudistaja nedostatochnost'. Osnovy diagnostiki i hirurgicheskogo lechenija / B.M.Mirolju-bov.—Kazan', 2003.
7. Miroljubov, B.M. // Kazan. med. zhurn.—2005.—№ 5.— S.412—415.
8. Miroljubov, B.M. // Annaly hirurgii.—2006.—№ 3.— S.62—65.
9. Miroljubov, B.M. // Kazan. med. zhurn.—2006.—№ 6.— S.456—461.
10. Flebologija / red. V.S.Savel'eva.—M., 2001.
11. Pokrovskij, A.V. Zabolevanija aorty i ee vetvej / A.V.Pok-rovskij.—M., 1979.
12. Possijskij konsensus // Rekomenduemye standar­ty dlja ocenki rezul'tatov lechenija pacientov s hronicheskoj ishemiej nizhnih konechnostej.—M., 2001.
13. Savel'ev, V.S. Jembolii bifurkacii aorty i magist­ral'nyh arterij konechnostej / V.S.Savel'ev, I.I.Zate-vahin, N.V Stepanov.—M., 1987.
14. Kistner, R.L., Eklof B., Masuda E.M // Mayo Clin. Proc.— 1996.—Vol.71, № 4.—P.422—423.
15. Psatakis, N.D., Psatakis D.N. // Vask. Surg.—1987.—P.192— 201.

 

Prevention of venous thromboembolic complications in patients with long lasting immobilization of lower extremities

R.I.Saleyev, S.A.Souslov, M.V.Potapova

Medical Unit of MIA in RT, Kazan, Russia

 

 

TO GENERAL PRACTITIONER

Diagnostic and therapeutic tactics in patients with portal hypertension.

A.Yu.Anisimov, A.F.Yakoupov, A.D.Junоusova

Kazan State Medical Academy, Kazan, Russia Interregional Clinical-Diagnostic Center, Kazan, Russia

Abstract. With today’s understanding of the position set out modern views on etiology, pathogenesis, classification, diagnostic methods, conservative and surgical treatment of patients with syndrome of portal hypertension. Summing up its own clinical experience treating 142 patients with syndrome of portal hypertension different genesis.

Key words: portal hypertension, diagnosis and surgical treatment.

 

References

1. Anisimov, A.Ju. Nastojashhee i budushhee hirurgii portal'¬noj gipertenzii / A.Ju.Anisimov, R.I.Tuishev, O.V.Bulasho-va // Kazan. med. zhurn.—2004.—T. LXXXY, № 2.—S.99—102.
2. Anisimov, A.Ju. Transplantacija kak metod lechenija bol'¬nyh s konechnymi stadijami diffuznyh zabolevanij pe¬cheni / A.Ju.Anisimov, M.V.Kuznecov // Kazan. med. zhurn.—2007.—T. LXXXYIII, № 3.—S.269—273.
3. Borisov, A.E. Krovotechenija portal'nogo geneza / A.E.Bo¬risov, M.I.Kuz'min-Kruteckij, V.A.Kashhenko [i dr.] // SPb.: NII Himii SpbGU OOP, 2001.—128 s.
4. Eramishancev, A.K. Jevoljucija hirurgicheskogo lechenija krovotechenij iz varikozno-rasshirennyh ven pishhevo- da i zheludka / A.K.Eramishancev // 50 lekcij po hirur-gii.—M.: Media Medika, 2003.—S.263—268. 7.
5. Zyjatdinov, K.Sh. Statistika zdorov'ja naselenija i zdra¬voohranenija (po materialam Respubliki Tatarstan za 8. 2001—2005 gody): ucheb.-metod. posobie / Kazan. gos. med. akad., Respub. med. inform.-analit. centr MZ RT; K.Sh.Zyjatdinov, A.A.Gil'manov, V.G.Sherputovskij [i 9. dr.]; pod red. I.G.Nizamova.—Kazan', 2006.—276 s.
6. Nazyrov, F.G. Hirurgija oslozhnenij portal'noj gi-pertenzii u bol'nyh cirrozom pecheni / F.G.Nazyrov, H.A.Akilov, A.V.Devjatov.—M., 2002.—410 s. Paciora, M.D. Hirurgija portal'noj gipertenzii / M.D.Paciora // Tashkent: Medicina, 1984.—319 s. Petrovskij, B.V. Hirurgija portal'noj gipertenzii (at¬las) / B.V.Petrovskij, K.N.Cacanidi, Ju.T.Kadoshhuk.—M.: AO «Medigrant», 1994.—183 s.
7. Sherlok, Sh. Zabolevanie pecheni i zhelchnyh putej: prak¬ticheskoe rukovodstvo: per. s angl.; Sh.Sherlok, Dzh.Du-li; pod red. Z.G.Aprosinoj, N.A.Muhina.—M.: Gjeotar-Medicina, 1999.—864 s.

 

CLINICAL OBSERVATIONS

To differential diagnosis of portal hypertention.

I.A.Gimaletdinova, S.R.Abdоulkhakov

Clinical Hospital of Medico-Sanitary Department of Ministry of Internal Affairs of Republic of Tatarstan, Kazan, Russia

Department of General Medical Practice of Kazan State Medical University, Kazan, Russia

Abstract. Portal hypertension is characterized with elevated portal pressure caused by blood flow disturbance of
different reasons and localization. According to the localization of blood flow block four types of portal hypertension
are distinguished. Differential diagnosis of these types is quite difficult. Timely diagnosis ensures rational treatment
of patients with poral hypertension. A clinical case of the patient with prehepatic portal hypertension is presented
here.

Key words: portal hypertension, esophageal varices, hypersplenism

 

Goodpasture’s syndrom

L.Kh.Safargaleyeva

Clinical hospital of MU of MIA in RT, Kazan, Russia

 

Clinical case of atrial fibrillation and pulmonary embolism.

E.B.Frolova, G.M.Kamalov, L.F.Mingazutdinova, O.Yu.Mikhoparova

Clinical Hospital of Medico-Sanitary Department of Ministry of Internal Affairs of Republic of Tatarstan, Kazan, Russia

Kazan State Medical University, Kazan, Russia

Abstract. The article presents the clinical case of patient suffering from paroxysmal form of ciliary arrhythmia with following tromboembolism of pulmonary artery segmental branches. The diagnosis of pulmonary tromboembolism has been verified by X-ray computed tomography. Control of heart rate and INR level at therapeutic range has allowed patients condition after pulmonary tromboembolism recurrence to be stabilized.

Key words: pulmonary tromboembolism, venous tromboembolism, atrial fibrillation, ciliary arrhythmia.

 

References

1. Petrovskij, B.V. Jekstrennaja hirurgija serdca i sosudov / B.V.Petrovskij, A.A.Bunjatjan.—M.: Medicina, 1980.
2. Savel'ev, V.S. Massivnaja jembolija legochnyh arterij / V.S.Savel'ev, E.G.Jablokov.—M.: Medicina, 1990.
3. Pokrovskij, A.V. Klinicheskaja angiologija / A.V.Pokrov-skij.—M.: Medicina, 1979.
4. Savel'ev, V.S. Trombojembolija legochnoj arterii / V.S.Savel'ev, E.G.Jablokov, A.I.Kirienko.—M.: Medici­na, 1975
5. Kotel'nikov, M.V. Trombojembolija legochnoj arterii (sovremennye podhody k diagnostike i lecheniju) / M.V.Kotel'nikov.—M., 2002.
6. Makarov, O.V. Profilaktika trombojembolicheskih oslozh­nenij v akusherskoj praktike / O.V.Makarov, L.A.Ozoli­nja, T.V.Parhomenko, S.B.Kerchelaeva // Ros. med. zhurn.— 1998.—№ 1.—S.28—32.
7. Rossijskij konsensus «Profilaktika posleoperacion­nyh venoznyh trombojembolicheskih oslozhnenij».—M., 2000.—20 s.
8. Savel'ev, V.S. Trombojembolija legochnyh arterij / V.S.Savel'ev, E.G.Jablokov, A.I.Kirienko.—M.: Medici­na, 1979.—264 s.
9. Planes, A. Risk of deep — venous thrombosis after hospital discharge in patients having undergane total hip replacement: double—blide randomised comparison of enoxaparin versus placebo / A.Planes, N.Vochelle, J.Darman // Lancet.—1996.—Vol.348.—P.224—228.

 

NEW TECHNOLOGIES AND TOOLS

The rehabilitation antistress program for internal affairs officers fulfilling mission in North Caucasian region.

I.A.Bоurenina, F.I.Ishkineyev, E.B.Frolova

Department of Rehabilitology and Sports Medicine of Kazan State Medical Academy, Kazan, Russia Clinical Hospital of Medico-Sanitary Department of Ministry of Internal Affairs of Republic of Tatarstan, Kazan, Russia

Abstract. The rehabilitation program for internal affairs officers returning from official trips from North Caucasian region has been developed and started its clinical testing. The offered rehabilitation program will allow efficient and quick normalizing of psycho-emotional status, workability restoring and overall health improving of internal affairs officers after physical and neuro-psychic stress.

Key words: medical-psychological adjustment, post-traumatic stress disorders, individual rehabilitation program.

 

References

1. Belova, A.N. Shkaly, testy i oprosniki v medicinskoj reabilitacii / A.N.Belova, O.N.Shhepetova.—M.: Anti-dor, 2002.—440 s.
2. Bogoljubov, V.M. Medicinskaja reabilitacija (rukovod­stvo): v 3 t. / pod red. V.M.Bogoljubova.—M., 2007.
3. Differencirovannaja sistema reabilitacii v narko­logii: metod. rekomendacii / T.N.Dudko, V.A.Puzienko, L.A.Kotel'nikova.—M., 2001.—38 s.
4. Epifanov, V.A. Medicinskaja reabilitacija: rukovod­stvo dlja vrachej / V.A.Epifanov.—M.: MEDpress-in-form, 2005.—328 s.
5. Zajcev, V.P. Psihologicheskaja reabilitacija bol'nyh / V.P.Zajcev // Medicinskaja reabilitacija (rukovodstvo) / pod red. V.M.Bogoljubova.—M., 2007.—T.1.—S.531—568.
6. Zaharova, N.N. Funkcional'nye izmenenija central'noj nervnoj sistemy pri vosprijatii muzyki / N.N.Zaharo­va, V.M.Avdeev // Zhurnal vysshej nervnoj dejatel'nos-ti.—1982.—T.32.—S.915—929.
7. Litvinova, T. Aromaterapija: professional'noe ruko­vodstvo v mire zapahov / T.Litvinova.—Rostov n/D.: Feniks, 2003.—416 s.
8. Organizacija vneplanovyh medicinskih i psihodiagno­sticheskih osmotrov (obsledovanij) sotrudnikov orga­nov vnutrennih del Rossijskoj Federacii, prinimaju­shhih uchastie v vypolnenii operativno-sluzhebnyh, slu-zhebno-boevyh i inyh zadach, soprjazhennyh s opasnost'ju dlja zhizni i prichineniju vreda zdorov'ju v osobyh us­lovijah: metod. posobie / M-vo vnutrennih del RF, De­partament tyla; sost.: N.I.Mjagkih, A.I.Ermachkov, A.I.Adaev [i dr.].—M., 2007.—38 s.
9. Organizacija mediko-psihologicheskogo obespechenija so­trudnikov organov vnutrennih del Rossijskoj Federa­cii, vypolnjajushhih zadachi v osobyh uslovijah: metod. po­sobie / GUK MVD Rossijskoj Federacii; pod obshh. red. zam. nachal'nika Departamenta tyla MVD Rossii, nachal'­nika mediko-social'noj zashhity, k.m.n D.V.Morozova; sost.: N.I.Mjagkih, A.V.Kaljaev, A.I.Ermachkov, G.V.Shutko.— M., 2005.—48 s.
10. Ocenka adaptacionnyh vozmozhnostej organizma i proble­my vosstanovitel'noj mediciny / R.M.Baevskij, A.L.Syr-kin, A.D.Ibatov, A.V.Sobolev, A.G.Chernikov // Vestnik vosstanovitel'noj mediciny.—2004.—№ 2.—S.19.
11. Pazhil'cev, I.V. Issledovanie osobennostej lichnosti sotrudnikov MVD, vypolnjajushhih professional'nuju dejatel'nost' v uslovijah real'noj vital'noj ugrozy / I.V.Pazhil'cev, I.A.Andreeva // Vestnik Sankt-Peter­burgskogo universiteta MVD Rossii.—№ 31.—2006.
12. Pazhil'cev, I.V. Psihologicheskie osobennosti lichno­sti sotrudnikov specpodrazdelenij MVD Rossii — ucha­stnikov kontrterroristicheskoj operacii na Severnom Kavkaze i ih psihoterapevticheskaja korrekcija: avtore­ferat dis. ... kand. psihol. nauk / I.V. Pazhil'cev.—SPb., 2007.—20 s.
13. Ponomarenko, G.N. Osnovy dokazatel'noj fizioterapii / G.N.Ponomarenko.—SPb.: VMedA, 2003.—224 s.
14. Ponomarenko, G.N. Chastnaja fizioterapija: ucheb. poso­bie/ G.N.Ponomarenko; pod. red. G.N.Ponomarenko.—M.: OAO «Izd-vo Medicina», 2005.—744 s.
15. Programma psihologicheskoj pomoshhi sotrudnikam i vo­ennosluzhashhim, osushhestvljajushhim kontrterroristiches­kie meroprijatija v Severo-Kavkazskom regione // MVD RF; Glavnoe upravlenie kadrov; Medicinskoe upravle-nie.—M., 2001.
16. Rukovodstvo po reabilitacii lic, podvegshihsja stres-sornym nagruzkam.—M.: Medicina, 2004 — 400 s.
17. Sazonova, L.A. Reabilitacija i vosstanovitel'naja te­rapija uchastnikov vooruzhennyh konfliktov / L.A.Sazo­nova, S.V.Arsent'eva // Psihopedagogika v pravoohra­nitel'nyh organah.—2002.—№ 2.
18. Shakula, A.V. Osnovnye napravlenija primenenija fizicheskih metodov polifaktornogo lechebno-ozdorovitel'nogo voz­dejstvija / A.V.Shakula, A.I.Truhanov, V.L.Bank // Vestnik vosstanovitel'noj mediciny.—2003.—№ 4.—S.19—25.
19. Shakula, A.V. Primenenie apparatno-programmnyh kom­pleksov polireceptornogo lechebno-ozdorovitel'nogo dejstvija v vosstanovitel'noj medicine / A.V.Shakula, A.I.Truhanov, V.L.Bank // Sovremennye tehnologii vos­stanovitel'noj mediciny / pod red. A.I.Truhanova.— M.: Medika, 2004.—S.234—256.

 

EXPERIENCE EXCHANGE, INNOVATIONS

Medical aid quality expertise department of the Medical Sanitary Department of the Ministry of Internal Affairs on RT and its activity in 2007— 2008.

A.D.Galioullin, M.V.Potapova, L.G.Gazimova

The Medical Sanitary Department of the Ministry of Internal Affairs on RT, Kazan, Russia

Abstract. The article presents report on activity of recently rormed subdivision of the Medical Sanitary Department of the Ministry of Internal Affairs on RT — Medical Aid Quality Expertise Department (MAQED); and on tasks and plans of the given department.

Key words: medical and quality expertise.

 

Family doctor activity at the Russian enterprise in the Republic of Guinea

V.S.Morokov

KIMBO hospital of РУСАЛ/ФРИГИЯ (Republic of Guinea) aluminium plant Kazan State Medical University, Russia

 

MEDICINE HISTORY

Historical aspects of development of studies on skin diseases

L.K.Bounakova, E.V.Faizoullina

Medical Unit of MIA in RT, Kazan, Russia Kazan State Medical University, Russia

УДК 617.7-022.7-078+616.98:579.882.11